H_Shan personal page - To The Moon

H_Shan

H_Shan

No personal profile

0Follow

0Followers

0Topic

0Badge

2021-04-05

Interesting

Sorry, the original content has been removed

2021-04-05

Nice

Sorry, the original content has been removed

2021-04-04

Nice

Tesla Q1 2021 Vehicle Production & Deliveries

2021-03-31

Nice

These Are The 5 Best Stocks To Buy And Watch Now

2021-03-31

Comment and like

Sorry, the original content has been removed

2021-03-30

Comment and like

Here’s why Wall Street and investors aren’t giddy enough, says top strategist

2021-03-28

Ok ok ok

2021-03-15

Like and comment

Sorry, the original content has been removed

2021-03-07

Like and comment

What's the Outlook for Intuitive Surgical?

2021-03-07

........

2021-02-27

Is this for long term?

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3577157678952273","uuid":"3577157678952273","gmtCreate":1614067253731,"gmtModify":1616664340542,"name":"H_Shan","pinyin":"hshanhshan","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":0,"tweetSize":15,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.24","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":349219322,"gmtCreate":1617614516866,"gmtModify":1704700851651,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577157678952273","authorIdStr":"3577157678952273"},"themes":[],"htmlText":"Interesting&nbsp;","listText":"Interesting&nbsp;","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/349219322","repostId":"1102809338","repostType":4,"isVote":1,"tweetType":1,"viewCount":331,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":349210777,"gmtCreate":1617614458399,"gmtModify":1704700850787,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577157678952273","authorIdStr":"3577157678952273"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/349210777","repostId":"2125768475","repostType":4,"isVote":1,"tweetType":1,"viewCount":362,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":340775440,"gmtCreate":1617500426080,"gmtModify":1704700009230,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577157678952273","authorIdStr":"3577157678952273"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/340775440","repostId":"2124875875","repostType":4,"repost":{"id":"2124875875","pubTimestamp":1617366960,"share":"https://ttm.financial/m/news/2124875875?lang=&edition=fundamental","pubTime":"2021-04-02 20:36","market":"us","language":"en","title":"Tesla Q1 2021 Vehicle Production & Deliveries","url":"https://stock-news.laohu8.com/highlight/detail?id=2124875875","media":"StreetInsider","summary":"PALO ALTO, Calif., April 02, 2021  -- In the first quarter, we produced just over 180,000 vehicles and delivered nearly 185,000 vehicles. We are encouraged by the strong reception of the Model Y in China and are quickly progressing to full production capacity. The new Model S and Model X have also been exceptionally well received, with the new equipment installed and tested in Q1 and we are in the early stages of ramping production.Forward-Looking Statements Statements herein regarding the timin","content":"<p>PALO ALTO, Calif., April 02, 2021 (GLOBE NEWSWIRE) -- In the first quarter, we produced just over 180,000 vehicles and delivered nearly 185,000 vehicles. We are encouraged by the strong reception of the Model Y in China and are quickly progressing to full production capacity. The new Model S and Model X have also been exceptionally well received, with the new equipment installed and tested in Q1 and we are in the early stages of ramping production.</p>\n<table>\n <tbody>\n  <tr>\n   <td></td>\n   <td><b>Production</b></td>\n   <td><b>Deliveries</b></td>\n   <td><b>Subject to operating lease accounting</b></td>\n  </tr>\n  <tr>\n   <td>Model S/X</td>\n   <td>-</td>\n   <td>2,020</td>\n   <td>6%</td>\n  </tr>\n  <tr>\n   <td>Model 3/Y</td>\n   <td>180,338</td>\n   <td>182,780</td>\n   <td>7%</td>\n  </tr>\n  <tr>\n   <td><b>Total</b></td>\n   <td><b>180,338</b></td>\n   <td><b>184,800</b></td>\n   <td><b>7%</b></td>\n  </tr>\n </tbody>\n</table>\n<p>***************</p>\n<p>Our net income and cash flow results will be announced along with the rest of our financial performance when we announce Q1 earnings. Our delivery count should be viewed as slightly conservative, as we only count a car as delivered if it is transferred to the customer and all paperwork is correct. Final numbers could vary by up to 0.5% or more. Tesla vehicle deliveries represent only <a href=\"https://laohu8.com/S/AONE\">one</a> measure of the company’s financial performance and should not be relied on as an indicator of quarterly financial results, which depend on a variety of factors, including the cost of sales, foreign exchange movements and mix of directly leased vehicles.</p>\n<p><b>Forward-Looking Statements</b>&nbsp;Statements herein regarding the timing and future progress of our vehicle production ramp are “forward-looking statements” based on management’s current expectations and that are subject to risks and uncertainties. Various important factors could cause actual results to differ materially, including the risks identified in our SEC filings. Tesla disclaims any obligation to update this information.</p>\n<p><img src=\"https://static.tigerbbs.com/db04c7b378cb2db912c3ba8a5a774ee3\" tg-width=\"1\" tg-height=\"1\" referrerpolicy=\"no-referrer\"></p>\n<p><img src=\"https://static.tigerbbs.com/c2196de8ba412c60c22ab491af7b1409\" tg-width=\"1\" tg-height=\"1\" referrerpolicy=\"no-referrer\"></p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Q1 2021 Vehicle Production & Deliveries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Q1 2021 Vehicle Production & Deliveries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-02 20:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18215929><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>PALO ALTO, Calif., April 02, 2021 (GLOBE NEWSWIRE) -- In the first quarter, we produced just over 180,000 vehicles and delivered nearly 185,000 vehicles. We are encouraged by the strong reception of ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18215929\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18215929","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2124875875","content_text":"PALO ALTO, Calif., April 02, 2021 (GLOBE NEWSWIRE) -- In the first quarter, we produced just over 180,000 vehicles and delivered nearly 185,000 vehicles. We are encouraged by the strong reception of the Model Y in China and are quickly progressing to full production capacity. The new Model S and Model X have also been exceptionally well received, with the new equipment installed and tested in Q1 and we are in the early stages of ramping production.\n\n\n\n\nProduction\nDeliveries\nSubject to operating lease accounting\n\n\nModel S/X\n-\n2,020\n6%\n\n\nModel 3/Y\n180,338\n182,780\n7%\n\n\nTotal\n180,338\n184,800\n7%\n\n\n\n***************\nOur net income and cash flow results will be announced along with the rest of our financial performance when we announce Q1 earnings. Our delivery count should be viewed as slightly conservative, as we only count a car as delivered if it is transferred to the customer and all paperwork is correct. Final numbers could vary by up to 0.5% or more. Tesla vehicle deliveries represent only one measure of the company’s financial performance and should not be relied on as an indicator of quarterly financial results, which depend on a variety of factors, including the cost of sales, foreign exchange movements and mix of directly leased vehicles.\nForward-Looking Statements Statements herein regarding the timing and future progress of our vehicle production ramp are “forward-looking statements” based on management’s current expectations and that are subject to risks and uncertainties. Various important factors could cause actual results to differ materially, including the risks identified in our SEC filings. Tesla disclaims any obligation to update this information.","news_type":1},"isVote":1,"tweetType":1,"viewCount":191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":354849386,"gmtCreate":1617161278145,"gmtModify":1704696618208,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577157678952273","authorIdStr":"3577157678952273"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/354849386","repostId":"1182614778","repostType":4,"repost":{"id":"1182614778","pubTimestamp":1617156798,"share":"https://ttm.financial/m/news/1182614778?lang=&edition=fundamental","pubTime":"2021-03-31 10:13","market":"us","language":"en","title":"These Are The 5 Best Stocks To Buy And Watch Now","url":"https://stock-news.laohu8.com/highlight/detail?id=1182614778","media":"INVESTOR'BUSINESS DAILY","summary":"Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard","content":"<p>Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist?<b>Ford</b>(F),<b>CarMax</b>(KMX)<b>Target</b>(TGT),<b>Scotts Miracle-Gro</b>(SMG) and the SPDR S&amp;P Metals &amp; Mining ETF (XME) are prime candidates.</p>\n<p>and shoulderspattern uh but we'll also take a look atVolume 0%</p>\n<p>Since the coronavirus bear market, stocks rebounded powerfully. The strong action reflects rising confidence that the economy will eventually recover from the coronavirus. The stock market has managed to get back on track after a brief correction, when all the major indexes all dipped below their50-day moving averages.</p>\n<p>Now is a good time to get back into the market, but caution should be exercised. It is somewhat akin to a tiger's tail - enticing enough to be worth grabbing, yet dangerous to hold on to too tightly due to possibly painful repercussions.</p>\n<p>The Nasdaq is still acting like it's in a correction trapped below its 50-day line. The Dow Jones and S&amp;P 500 ended March 26 at record closes.</p>\n<p>The coronavirus pandemic remains a concern, though new cases and deaths are well off highs while vaccinations are ramping up. President Joe Biden has signed the $1.9 trillion coronavirus stimulus bill.&nbsp;Fed Chairman Jerome Powell has saidthat the central bank is committed to an \"all-in\" approach as it tries to nurse the economy back to health.</p>\n<p>There are concerns thataggressive fiscal and monetary policycould spur too-much inflation and hurt stock prices long-term.</p>\n<p>So why do the stocks chosen stand out? Before turning to that question, it is important to consider how one goes about choosing a stock in the first place. Superior fundamentals and technical action, and buying at the right time, are all part of a shrewd investing formula.</p>\n<p>Best Stocks To Buy: The Crucial Ingredients</p>\n<p>Remember, there are thousands of stocks trading on the NYSE and Nasdaq. But you want to find the very best stocks right now to generate massive gains.</p>\n<p>TheCAN SLIM systemoffers clear guidelines on what you should be looking for. Invest in stocks with recent quarterly and annual earnings growth of at least 25%. Look for companies that have new, game-changing products and services. Also consider not-yet-profitable companies, often recent IPOs, that are generating tremendous revenue growth.</p>\n<p>IBD'sCAN SLIM Investing Systemhas a proven track record of significantly outperforming the S&amp;P 500. Outdoing this industry benchmark is key to generating exceptional returns over the long term.</p>\n<p>In addition, keep an eye on supply and demand for the stock itself, focus on leading stocks in top industry groups, and aim for stocks with strong institutional support.</p>\n<p>Once you have found a stock that fits the criteria, it is then time to turn to stock charts to plot agood entry point. You should wait for a stock toform a base, and then buy once it reaches abuy point, ideally in heavy volume. In many cases, a stock reaches aproper buy pointwhen it breaks above the original high on the left side of the base. More information on what a base is, and how charts can be used to&nbsp;win big on the stock market, can be found here.</p>\n<p>Don't Forget The M When Buying Stocks</p>\n<p>Never forget that theM in CAN SLIM stands for market. Most stocks, even the very best, will tend to follow the market direction. Invest when the stock market is in aconfirmed uptrendand move to cash when the stock market goes into a correction.</p>\n<p>The Dow Jones Industrial Average, Nasdaq and the S&amp;P 500 rallied strongly after recent pressure. The S&amp;P 500 and the Dow Jones have recaptured their50-day moving averages, but are meeting resistance. The Nasdaq also briefly traded above this key benchmark, but slipped back below it. Technology and growth stocks are still showing signs of weakness.</p>\n<p>It is now is a good time to get back into the market and buy fundamentally strong stocks coming out of proper chart bases. But this is no longer the powerful, growth stock rally of 2020.</p>\n<p>The stocks featured below are potential candidates.</p>\n<p>As you identify stocks, on a technical basis look for stocks with rising relative strength lines. Stocks that hold up amid tough conditions often bound to new highs once a market stabilizes.</p>\n<p>Remember, things can quickly change when it comes to the stock market. Make sure you don't miss out on a rally by keeping a close eye on themarket trend page here.</p>\n<p>Best Stocks To Buy Or Watch</p>\n<p>Now let's look at Ford stock, CarMax stock, Target stock, Scotts Miracle-Gro stock and XME in more detail. An important consideration is that these stocks all boast impressive relative strength.</p>\n<p>Ford&nbsp;Stock</p>\n<p>Ford&nbsp;stock&nbsp;is just above a 12.14 buy point after previously clearing a&nbsp;three-weeks-tightpattern. It is also rebounding from its 10-week moving average, which also serves as entry.</p>\n<p>The RS line has been falling back after a strong spike from early January until mid-March. From a longer term perspective, it has been making progress, with periodic pullbacks, since May 2020. It is now at levels last seen in early 2019.</p>\n<p>Ford&nbsp;stockhas more than tripled from its 2020 lows. This improvingstockmarket performance has helped itsIBD Composite Ratingimprove to a strong, but not ideal, 87. This puts it in the top 13% of stocks tracked overall.</p>\n<p>Earnings are improving, but are lagging its price performance. This is reflected in its EPS Rating of 75.</p>\n<p>Ford&nbsp;stockhas been bolstered by the firm taking a more aggressive stance on investments in electric vehicles and other technology.</p>\n<p>Spending in electric and autonomous vehicles will total $29 billion through 2025, more than double prior guidance of $11.5 billion. Of the $29 billion,&nbsp;Ford&nbsp;will spend $22 billion on EVs and $7 billion on autonomy.</p>\n<p>The bigger amount even outpaces the $27 billion commitment from rival GM, which had already hiked it from $20 billion.</p>\n<p>\"We are accelerating all our plans – breaking constraints, increasing battery capacity, improving costs and getting more electric vehicles into our product cycle plan,\" CEO Jim Farley said when the firm posted earnings in February.</p>\n<p>However, the company said chip shortages will hurt production and profit this year. It has had to cut production of its lucrative F-150 pickup due to chip shortages.</p>\n<p>The iconic auto giant is ticking boxes forCAN SLIM investors, who look out for firms bringing new products to market.</p>\n<p>The Ford Mustang Mach-E launched at the end of 2020 and picked up steam in February. The electric crossover competes with Tesla's Model Y.</p>\n<p>Fordalso has launched the Mach-E in Europeand has begun production of the Mach-E in China.</p>\n<p>It is also&nbsp;an investor in electric truck maker Rivian, whose shares could go public&nbsp;as soon as September and set a record for the biggest EV IPO.</p>\n<p>Ford&nbsp;stock rose&nbsp;in February after it announced a six-year partnership with Google parent&nbsp;<b>Alphabet</b>&nbsp;(GOOGL) to develop more connected vehicles. The partnership will put Google apps and services into future&nbsp;Ford&nbsp;and Lincoln vehicles.</p>\n<p>CarMax Stock</p>\n<p>CarMax stock is near buy zone after breaking out of aflat base. The idealentry point is 128.68, according to&nbsp;MarketSmith analysis.</p>\n<p>The used car dealer chain rebounded strongly last week after test its 10-week line and briefly undercutting the buy point.</p>\n<p>KMX stock also has a three-weeks-tight around the top of the buy zone. That offers an alternate entry of 136.53.</p>\n<p>In addition, therelative strength linefor CarMax stock is looking mighty. It is sitting near all-time highs on its weekly chart, and has been trending upwards since early January. The stock is up more around 44% so far this year.</p>\n<p>KMX stock has a strong, but not ideal,&nbsp;IBD Composite Rating of 89. Earnings are the standout strength for KMX stock, with itsEPS Rating coming in at 90 out of 99.</p>\n<p>It has been affected by the initial coronavirus lockdowns, butEPS roared back to 37% growth&nbsp;in the most recent quarter. Earnings have accelerated for the past two quarters.</p>\n<p>Analysts see earnings falling 16% in 2021, before roaring back with growth of 27% in 2022.</p>\n<p>Big money is piling in, with its&nbsp;Accumulation/Distribution Rating coming in at B+. This represents moderate-to-heavy buying over the past 13 weeks. In total, 57% of its stock is held by funds.</p>\n<p>CarMax operates used car stores in more than 70 metropolitan markets. It is a recentIBD Stock Of The Day.</p>\n<p>CarMax's network of 220 stores nationwide sold more than 830,000 used cars in its last financial year. Overall used vehicle sales are expected to rise 2.9% in 2021 to 39.3 million, according to Cox Automotive.</p>\n<p>For Q3, it reported more than 50% of customers chose to advance their transaction online. It has expanded in home delivery and contactless curbside pickup, tapping new avenues of growth.</p>\n<p>\"We are on track for most of our customers to have the ability to buy vehicle online independently if they choose by the middle of next fiscal year,\" CEO Bill Nash said on an earnings call last December.</p>\n<p>Meanwhile, more consumers moved to the used car market during the pandemic. At the same time, used car prices rose on a combination of factors.</p>\n<p>The pandemic strained Americans' wallets, forcing consumers to hold on to old cars longer and making fewer used cars available for sale. People also sought to avoid mass transportation. Rising new car prices, partly due to limited supply, also turned more shoppers to the used market.</p>\n<p>Target Stock</p>\n<p>Target&nbsp;stock is in buy zone after breaking out of a new double-bottom base. The ideal buy point here is 196.35. The stock aggressively sprinted away from its 10-week line as it broke out.</p>\n<p>In fact TGTstockhas broken clear of all its major technical benchmarks, including its21-day exponential moving average. This is a very bullish behavior.</p>\n<p>The RS line offers further reasons for enthusiasm among Target investors. It is spiking higher once more, and could soon hit a new high.</p>\n<p>Target stock has a good Composite Rating of 87, putting it in top 13% ofstocks tracked. Earnings in particular are a strength, with&nbsp;EPS rising by an average of 83% over the past three quarters. Earnings rose by a less impressive, but still strong, 58% in the most recent quarter.</p>\n<p>Institutional sentiment is also strong, with itsAccumulation/Distribution Ratingcoming in at B-. This reflects moderate buying among institutions. Notable holders include the Fidelity Select Retailing Portfolio Fund (FSRPX), which ranks as one of the very best funds according to IBD research.</p>\n<p>Target recently announced it will invest$4 billion a year for several years to accelerate its shift to e-commerce</p>\n<p>During a virtual investor day, management said the massive investment campaign would include 30-40 new stores each year, new distribution centers and technology aimed at speeding up shelf restocking.</p>\n<p>Target will also test new package-sorting hubs and look for ways to design more efficient delivery routes.</p>\n<p>The company's focus on revamping its stores to serve more as fulfillment centers for online orders was well under way before Covid-19 hit. It is working to regain market share lost to online retail giant<b>Amazon</b>(AMZN)<b>.</b></p>\n<p>Scotts Miracle-Gro Stock</p>\n<p>Scotts Miracle-Gro stock has broken out of a cup-with-handle base, clearing the 238.91 buy point on March 26. SMG stock rebounded from its 50-day line the prior day.</p>\n<p>The relative strength line for Scotts Miracle-Gro stock has been recovering strongly from recent dip, and could soon reach new highs.</p>\n<p>So far in 2021, the stock is up more than 21%.</p>\n<p>SMG stock has a good balance of earnings and price performance. This has earned it a top notch Composite Rating of 97. This puts it in the top 3% of stocks tracked.</p>\n<p>Scotts Miracle-Gro stock is&nbsp;particularly noteworthy for marijuana enthusiasts. The lawn care specialist has been investing in R&amp;D for better plant genetics and nutrient formulations for both cannabis and hemp plants.</p>\n<p>SMG took part in the marijuana stock rally that followed the Jan. 5 runoff elections in Georgia, granting a de facto majority in the U.S. Senate to the Democratic Party.</p>\n<p>Big money is getting behind SMG stock, with itsAccumulation/Distribution Ratingcoming in at B-. The Federated Hermes Kaufmann Fund (KAUFX), rated as one of the best funds by IBD, is a noteworthy holder. In total, 49% of its stock is held by funds.</p>\n<p>Management holds a further 27%. A large management stake in a company is often seen as a sign of strong future prospects.</p>\n<p>XME</p>\n<p>The metals and mining ETF has charged back into buy zone after a powerful rebound from its 10-week line. It comes after the stock painfully reversed after breaking out of a 38.09cup base entry.</p>\n<p>The rebound is particularly impressive when one considers the RS line has taken a slight dip. Overall, the ETF'srelative strength linehas been making good progress since November.</p>\n<p>Investing in individual stocks can carry more volatility and risk, though the rewards can be far greater. Investing in an ETF provides a way to play an entire industry.</p>\n<p>XME offers a good opportunity for those wanting to play the macro changes in the mining environment. Nevertheless, XME has still been displaying plenty of volatility amid a seesaw market. The rewards are obvious when one considers it has gained almost 20% in 2021 however.</p>\n<p>Holdings include the likes of<b>Alcoa</b>(AA) and<b>Freeport-McMoRan</b>(FCX),<b>Steel Dynamics</b>(STLD) and<b>Royal Gold</b>(RGLD).</p>\n<p>The gains for the ETF and other mining stocks come with a broader economic rebound from the coronavirus pandemic. As the economy reopens, some investors are betting demand for metal materials, and demand for more such materials to be mined from the earth, will recover with it.</p>\n<p>\"Commodity markets have strengthened as the outlook for demand is improving and supply constraints are increasing,\" Jefferies mining stocks analysts said in a research note last month.</p>\n<p>Commodity prices for things like iron ore and nickel stood at multiyear highs earlier this year. Mining stocks have also been buoyed by prospects for more U.S. infrastructure spending.</p>","source":"lsy1617156785392","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These Are The 5 Best Stocks To Buy And Watch Now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese Are The 5 Best Stocks To Buy And Watch Now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-31 10:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/research/best-stocks-to-buy-now/?src=A00220><strong>INVESTOR'BUSINESS DAILY</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist?Ford(F),CarMax(KMX)Target(TGT),Scotts...</p>\n\n<a href=\"https://www.investors.com/research/best-stocks-to-buy-now/?src=A00220\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.investors.com/research/best-stocks-to-buy-now/?src=A00220","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182614778","content_text":"Buying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So what are the best stocks to buy now or put on a watchlist?Ford(F),CarMax(KMX)Target(TGT),Scotts Miracle-Gro(SMG) and the SPDR S&P Metals & Mining ETF (XME) are prime candidates.\nand shoulderspattern uh but we'll also take a look atVolume 0%\nSince the coronavirus bear market, stocks rebounded powerfully. The strong action reflects rising confidence that the economy will eventually recover from the coronavirus. The stock market has managed to get back on track after a brief correction, when all the major indexes all dipped below their50-day moving averages.\nNow is a good time to get back into the market, but caution should be exercised. It is somewhat akin to a tiger's tail - enticing enough to be worth grabbing, yet dangerous to hold on to too tightly due to possibly painful repercussions.\nThe Nasdaq is still acting like it's in a correction trapped below its 50-day line. The Dow Jones and S&P 500 ended March 26 at record closes.\nThe coronavirus pandemic remains a concern, though new cases and deaths are well off highs while vaccinations are ramping up. President Joe Biden has signed the $1.9 trillion coronavirus stimulus bill. Fed Chairman Jerome Powell has saidthat the central bank is committed to an \"all-in\" approach as it tries to nurse the economy back to health.\nThere are concerns thataggressive fiscal and monetary policycould spur too-much inflation and hurt stock prices long-term.\nSo why do the stocks chosen stand out? Before turning to that question, it is important to consider how one goes about choosing a stock in the first place. Superior fundamentals and technical action, and buying at the right time, are all part of a shrewd investing formula.\nBest Stocks To Buy: The Crucial Ingredients\nRemember, there are thousands of stocks trading on the NYSE and Nasdaq. But you want to find the very best stocks right now to generate massive gains.\nTheCAN SLIM systemoffers clear guidelines on what you should be looking for. Invest in stocks with recent quarterly and annual earnings growth of at least 25%. Look for companies that have new, game-changing products and services. Also consider not-yet-profitable companies, often recent IPOs, that are generating tremendous revenue growth.\nIBD'sCAN SLIM Investing Systemhas a proven track record of significantly outperforming the S&P 500. Outdoing this industry benchmark is key to generating exceptional returns over the long term.\nIn addition, keep an eye on supply and demand for the stock itself, focus on leading stocks in top industry groups, and aim for stocks with strong institutional support.\nOnce you have found a stock that fits the criteria, it is then time to turn to stock charts to plot agood entry point. You should wait for a stock toform a base, and then buy once it reaches abuy point, ideally in heavy volume. In many cases, a stock reaches aproper buy pointwhen it breaks above the original high on the left side of the base. More information on what a base is, and how charts can be used to win big on the stock market, can be found here.\nDon't Forget The M When Buying Stocks\nNever forget that theM in CAN SLIM stands for market. Most stocks, even the very best, will tend to follow the market direction. Invest when the stock market is in aconfirmed uptrendand move to cash when the stock market goes into a correction.\nThe Dow Jones Industrial Average, Nasdaq and the S&P 500 rallied strongly after recent pressure. The S&P 500 and the Dow Jones have recaptured their50-day moving averages, but are meeting resistance. The Nasdaq also briefly traded above this key benchmark, but slipped back below it. Technology and growth stocks are still showing signs of weakness.\nIt is now is a good time to get back into the market and buy fundamentally strong stocks coming out of proper chart bases. But this is no longer the powerful, growth stock rally of 2020.\nThe stocks featured below are potential candidates.\nAs you identify stocks, on a technical basis look for stocks with rising relative strength lines. Stocks that hold up amid tough conditions often bound to new highs once a market stabilizes.\nRemember, things can quickly change when it comes to the stock market. Make sure you don't miss out on a rally by keeping a close eye on themarket trend page here.\nBest Stocks To Buy Or Watch\nNow let's look at Ford stock, CarMax stock, Target stock, Scotts Miracle-Gro stock and XME in more detail. An important consideration is that these stocks all boast impressive relative strength.\nFord Stock\nFord stock is just above a 12.14 buy point after previously clearing a three-weeks-tightpattern. It is also rebounding from its 10-week moving average, which also serves as entry.\nThe RS line has been falling back after a strong spike from early January until mid-March. From a longer term perspective, it has been making progress, with periodic pullbacks, since May 2020. It is now at levels last seen in early 2019.\nFord stockhas more than tripled from its 2020 lows. This improvingstockmarket performance has helped itsIBD Composite Ratingimprove to a strong, but not ideal, 87. This puts it in the top 13% of stocks tracked overall.\nEarnings are improving, but are lagging its price performance. This is reflected in its EPS Rating of 75.\nFord stockhas been bolstered by the firm taking a more aggressive stance on investments in electric vehicles and other technology.\nSpending in electric and autonomous vehicles will total $29 billion through 2025, more than double prior guidance of $11.5 billion. Of the $29 billion, Ford will spend $22 billion on EVs and $7 billion on autonomy.\nThe bigger amount even outpaces the $27 billion commitment from rival GM, which had already hiked it from $20 billion.\n\"We are accelerating all our plans – breaking constraints, increasing battery capacity, improving costs and getting more electric vehicles into our product cycle plan,\" CEO Jim Farley said when the firm posted earnings in February.\nHowever, the company said chip shortages will hurt production and profit this year. It has had to cut production of its lucrative F-150 pickup due to chip shortages.\nThe iconic auto giant is ticking boxes forCAN SLIM investors, who look out for firms bringing new products to market.\nThe Ford Mustang Mach-E launched at the end of 2020 and picked up steam in February. The electric crossover competes with Tesla's Model Y.\nFordalso has launched the Mach-E in Europeand has begun production of the Mach-E in China.\nIt is also an investor in electric truck maker Rivian, whose shares could go public as soon as September and set a record for the biggest EV IPO.\nFord stock rose in February after it announced a six-year partnership with Google parent Alphabet (GOOGL) to develop more connected vehicles. The partnership will put Google apps and services into future Ford and Lincoln vehicles.\nCarMax Stock\nCarMax stock is near buy zone after breaking out of aflat base. The idealentry point is 128.68, according to MarketSmith analysis.\nThe used car dealer chain rebounded strongly last week after test its 10-week line and briefly undercutting the buy point.\nKMX stock also has a three-weeks-tight around the top of the buy zone. That offers an alternate entry of 136.53.\nIn addition, therelative strength linefor CarMax stock is looking mighty. It is sitting near all-time highs on its weekly chart, and has been trending upwards since early January. The stock is up more around 44% so far this year.\nKMX stock has a strong, but not ideal, IBD Composite Rating of 89. Earnings are the standout strength for KMX stock, with itsEPS Rating coming in at 90 out of 99.\nIt has been affected by the initial coronavirus lockdowns, butEPS roared back to 37% growth in the most recent quarter. Earnings have accelerated for the past two quarters.\nAnalysts see earnings falling 16% in 2021, before roaring back with growth of 27% in 2022.\nBig money is piling in, with its Accumulation/Distribution Rating coming in at B+. This represents moderate-to-heavy buying over the past 13 weeks. In total, 57% of its stock is held by funds.\nCarMax operates used car stores in more than 70 metropolitan markets. It is a recentIBD Stock Of The Day.\nCarMax's network of 220 stores nationwide sold more than 830,000 used cars in its last financial year. Overall used vehicle sales are expected to rise 2.9% in 2021 to 39.3 million, according to Cox Automotive.\nFor Q3, it reported more than 50% of customers chose to advance their transaction online. It has expanded in home delivery and contactless curbside pickup, tapping new avenues of growth.\n\"We are on track for most of our customers to have the ability to buy vehicle online independently if they choose by the middle of next fiscal year,\" CEO Bill Nash said on an earnings call last December.\nMeanwhile, more consumers moved to the used car market during the pandemic. At the same time, used car prices rose on a combination of factors.\nThe pandemic strained Americans' wallets, forcing consumers to hold on to old cars longer and making fewer used cars available for sale. People also sought to avoid mass transportation. Rising new car prices, partly due to limited supply, also turned more shoppers to the used market.\nTarget Stock\nTarget stock is in buy zone after breaking out of a new double-bottom base. The ideal buy point here is 196.35. The stock aggressively sprinted away from its 10-week line as it broke out.\nIn fact TGTstockhas broken clear of all its major technical benchmarks, including its21-day exponential moving average. This is a very bullish behavior.\nThe RS line offers further reasons for enthusiasm among Target investors. It is spiking higher once more, and could soon hit a new high.\nTarget stock has a good Composite Rating of 87, putting it in top 13% ofstocks tracked. Earnings in particular are a strength, with EPS rising by an average of 83% over the past three quarters. Earnings rose by a less impressive, but still strong, 58% in the most recent quarter.\nInstitutional sentiment is also strong, with itsAccumulation/Distribution Ratingcoming in at B-. This reflects moderate buying among institutions. Notable holders include the Fidelity Select Retailing Portfolio Fund (FSRPX), which ranks as one of the very best funds according to IBD research.\nTarget recently announced it will invest$4 billion a year for several years to accelerate its shift to e-commerce\nDuring a virtual investor day, management said the massive investment campaign would include 30-40 new stores each year, new distribution centers and technology aimed at speeding up shelf restocking.\nTarget will also test new package-sorting hubs and look for ways to design more efficient delivery routes.\nThe company's focus on revamping its stores to serve more as fulfillment centers for online orders was well under way before Covid-19 hit. It is working to regain market share lost to online retail giantAmazon(AMZN).\nScotts Miracle-Gro Stock\nScotts Miracle-Gro stock has broken out of a cup-with-handle base, clearing the 238.91 buy point on March 26. SMG stock rebounded from its 50-day line the prior day.\nThe relative strength line for Scotts Miracle-Gro stock has been recovering strongly from recent dip, and could soon reach new highs.\nSo far in 2021, the stock is up more than 21%.\nSMG stock has a good balance of earnings and price performance. This has earned it a top notch Composite Rating of 97. This puts it in the top 3% of stocks tracked.\nScotts Miracle-Gro stock is particularly noteworthy for marijuana enthusiasts. The lawn care specialist has been investing in R&D for better plant genetics and nutrient formulations for both cannabis and hemp plants.\nSMG took part in the marijuana stock rally that followed the Jan. 5 runoff elections in Georgia, granting a de facto majority in the U.S. Senate to the Democratic Party.\nBig money is getting behind SMG stock, with itsAccumulation/Distribution Ratingcoming in at B-. The Federated Hermes Kaufmann Fund (KAUFX), rated as one of the best funds by IBD, is a noteworthy holder. In total, 49% of its stock is held by funds.\nManagement holds a further 27%. A large management stake in a company is often seen as a sign of strong future prospects.\nXME\nThe metals and mining ETF has charged back into buy zone after a powerful rebound from its 10-week line. It comes after the stock painfully reversed after breaking out of a 38.09cup base entry.\nThe rebound is particularly impressive when one considers the RS line has taken a slight dip. Overall, the ETF'srelative strength linehas been making good progress since November.\nInvesting in individual stocks can carry more volatility and risk, though the rewards can be far greater. Investing in an ETF provides a way to play an entire industry.\nXME offers a good opportunity for those wanting to play the macro changes in the mining environment. Nevertheless, XME has still been displaying plenty of volatility amid a seesaw market. The rewards are obvious when one considers it has gained almost 20% in 2021 however.\nHoldings include the likes ofAlcoa(AA) andFreeport-McMoRan(FCX),Steel Dynamics(STLD) andRoyal Gold(RGLD).\nThe gains for the ETF and other mining stocks come with a broader economic rebound from the coronavirus pandemic. As the economy reopens, some investors are betting demand for metal materials, and demand for more such materials to be mined from the earth, will recover with it.\n\"Commodity markets have strengthened as the outlook for demand is improving and supply constraints are increasing,\" Jefferies mining stocks analysts said in a research note last month.\nCommodity prices for things like iron ore and nickel stood at multiyear highs earlier this year. Mining stocks have also been buoyed by prospects for more U.S. infrastructure spending.","news_type":1},"isVote":1,"tweetType":1,"viewCount":415,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":354857401,"gmtCreate":1617161179103,"gmtModify":1704696617725,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577157678952273","authorIdStr":"3577157678952273"},"themes":[],"htmlText":"Comment and like","listText":"Comment and like","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/354857401","repostId":"1163996400","repostType":4,"isVote":1,"tweetType":1,"viewCount":353,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":355716840,"gmtCreate":1617104867480,"gmtModify":1704695868609,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577157678952273","authorIdStr":"3577157678952273"},"themes":[],"htmlText":"Comment and like","listText":"Comment and like","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/355716840","repostId":"1162058288","repostType":4,"repost":{"id":"1162058288","pubTimestamp":1617104066,"share":"https://ttm.financial/m/news/1162058288?lang=&edition=fundamental","pubTime":"2021-03-30 19:34","market":"us","language":"en","title":"Here’s why Wall Street and investors aren’t giddy enough, says top strategist","url":"https://stock-news.laohu8.com/highlight/detail?id=1162058288","media":"marketwatch","summary":"Critical information for the U.S. trading day.While the footing has been a bit less steady for stock","content":"<blockquote><b>Critical information for the U.S. trading day.</b></blockquote><p>While the footing has been a bit less steady for stocks lately, March is still set to deliver solid gains for most of Wall Street, with the Dow Jones Industrial Average DJIA, +0.30% up 7% and the S&amp;P 500 SPX, -0.09% up 4%. The Nasdaq Composite COMP, -0.60% is lagging with a 1% drop as the shift toward cyclical stocks continues.</p><p>The big bull calls for this market remain scarce though, and that may be down to some disbelief, said Jim Paulsen, chief investment strategist at money management and research firm The Leuthold Group.</p><blockquote>“I just can’t imagine that at that point, when, in some sense in this country, when we declare victory over COVID that we’re not going to feel a whole lot more giddy than we do right now sitting in my basement.”&nbsp;— Jim Paulsen, The Leuthold Group</blockquote><p>“There’s a lot of thought that people are too giddy, there’s too much optimism, sentiment is too strong, but I just can’t help but feel it’s going to be a lot stronger,” said Paulsen, in an interview on Monday with MarketWatch.</p><p>In our call of the day, he brushes away the naysayers, and looks ahead to the coming autumn, when almost everyone in the U.S. who wants a COVID-19 vaccine will get one, and we’ve got reopenings, re-employment and people “flush with stimulus” cash.</p><p>“I just can’t imagine that at that point, when, in some sense in this country, when we declare victory over COVID that we’re not going to feel a whole lot more giddy than we do right now sitting in my basement,” including growth better than 8% this year, Paulsen said. “So I think that sentiment is going to run through Main Street and Wall Street.”</p><p>Fundamentals go along with that, as he expects U.S. growth of better than 8% this year, among the strongest of the postwar era. Earnings are also expected to surge, with Wall Street forecasting a rebound for S&amp;P 500 earnings to $175 this year — Paulsen sees $200 as possible.</p><p>“And if it does, that means we’re selling on less than 20 times earnings right now on the S&amp;P 500, and probably broader markets are even better valuation,” he said. What he thinks is happening is that sentiment just can’t keep up with the better-and-better scenario unfolding.</p><p>“There’s not another period I can think of in postwar history where we effectively took the world economy to a Depression-era bust, and then within about a year…a postwar boom,” he said. And while rising bond yields — something to watch for Tuesday — hover over investors, Paulsen sees a “stepwise” move up to 2%.</p><p>For investors, he suggests continuing to steer toward economically sensitive areas, via cyclical, small cap and international stocks. He owns technology, but is underweight as sees some underperformance ahead. “But I don’t think it’s going to crater. I think it’s going to participate in this bull.”</p><p>Investors shouldn’t abandon the sector, because it has been such a domineering force throughout the globe. And down the road, he said tech companies, because they permeate so many sectors, may start to be categorized differently.</p><p><img src=\"https://static.tigerbbs.com/1c4d059b2a2272b5b365afd8aafaf2ba\" tg-width=\"1242\" tg-height=\"1096\" referrerpolicy=\"no-referrer\"></p><p>What to avoid? Paulsen said he would be wary of healthcare, utilities, real-estate investment trusts, cash, bonds, gold. And yes he does see a correction likely, a big risk for this year.</p><p>“I think it might come later this year but I wouldn’t be shocked, starting right now,” he said. “And that’s the biggest risk this year and I don’t think that’s a cycle ender, it certainly is painful. And I think we’re going to get one of those.”</p><p><b>Yields are creeping up, Archegos lingers</b></p><p>Tech stocks are struggling to get a foothold in a holiday-shortened week, with futures for the Nasdaq-100 NQ00, -0.75% down. Those for the S&amp;P 500 ES00, -0.33% and Dow YM00, -0.11% are flat to higher. But the yield on the 10-year U.S. Treasury TMUBMUSD10Y, 1.762% is up to nearly 1.77%. The Case-Shiller home price index and a gauge of consumer confidence are the data ahead.</p><p>Score another for cryptocurrencies. U.S. customers of online payment provider PayPal PYPL, -2.22% can now purchase items with bitcoin BTCUSD, 3.26% and other digital assets.</p><p>European stocks and banks SXXP, 0.33% are getting a breather after Monday’s selloff, led by Credit Suisse CS, -11.50%. That is as Archegos Capital Management, the U.S. fund believed to be behind the forced sale of more than $20 billion in stocks, says “all plans are being discussed.” Wall Street banks were reportedly summoned by U.S. regulators to discuss the risks and fallout.</p><p><img src=\"https://static.tigerbbs.com/b1fe433f659d25ba084fd1f7b41b448d\" tg-width=\"1080\" tg-height=\"1514\" referrerpolicy=\"no-referrer\"></p><p>The COVID-19 vaccines from drug company Pfizer PFE, +1.02% and biotech Moderna MRNA, -7.40% stopped infections and illness in 90% of fully vaccinated people. Meanwhile, Canada has suspended the shots from drug company AstraZeneca AZN, +0.34% for adults under 55.</p><p>The New York City Police Department is hunting the suspect of a vicious assault on an elderly Asian-American woman.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here’s why Wall Street and investors aren’t giddy enough, says top strategist</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere’s why Wall Street and investors aren’t giddy enough, says top strategist\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-30 19:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/heres-why-wall-street-and-investors-arent-giddy-enough-says-top-strategist-11617102861><strong>marketwatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Critical information for the U.S. trading day.While the footing has been a bit less steady for stocks lately, March is still set to deliver solid gains for most of Wall Street, with the Dow Jones ...</p>\n\n<a href=\"https://www.marketwatch.com/story/heres-why-wall-street-and-investors-arent-giddy-enough-says-top-strategist-11617102861\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/9a5677649fbdbb7ef0087796f2311fad","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/heres-why-wall-street-and-investors-arent-giddy-enough-says-top-strategist-11617102861","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162058288","content_text":"Critical information for the U.S. trading day.While the footing has been a bit less steady for stocks lately, March is still set to deliver solid gains for most of Wall Street, with the Dow Jones Industrial Average DJIA, +0.30% up 7% and the S&P 500 SPX, -0.09% up 4%. The Nasdaq Composite COMP, -0.60% is lagging with a 1% drop as the shift toward cyclical stocks continues.The big bull calls for this market remain scarce though, and that may be down to some disbelief, said Jim Paulsen, chief investment strategist at money management and research firm The Leuthold Group.“I just can’t imagine that at that point, when, in some sense in this country, when we declare victory over COVID that we’re not going to feel a whole lot more giddy than we do right now sitting in my basement.” — Jim Paulsen, The Leuthold Group“There’s a lot of thought that people are too giddy, there’s too much optimism, sentiment is too strong, but I just can’t help but feel it’s going to be a lot stronger,” said Paulsen, in an interview on Monday with MarketWatch.In our call of the day, he brushes away the naysayers, and looks ahead to the coming autumn, when almost everyone in the U.S. who wants a COVID-19 vaccine will get one, and we’ve got reopenings, re-employment and people “flush with stimulus” cash.“I just can’t imagine that at that point, when, in some sense in this country, when we declare victory over COVID that we’re not going to feel a whole lot more giddy than we do right now sitting in my basement,” including growth better than 8% this year, Paulsen said. “So I think that sentiment is going to run through Main Street and Wall Street.”Fundamentals go along with that, as he expects U.S. growth of better than 8% this year, among the strongest of the postwar era. Earnings are also expected to surge, with Wall Street forecasting a rebound for S&P 500 earnings to $175 this year — Paulsen sees $200 as possible.“And if it does, that means we’re selling on less than 20 times earnings right now on the S&P 500, and probably broader markets are even better valuation,” he said. What he thinks is happening is that sentiment just can’t keep up with the better-and-better scenario unfolding.“There’s not another period I can think of in postwar history where we effectively took the world economy to a Depression-era bust, and then within about a year…a postwar boom,” he said. And while rising bond yields — something to watch for Tuesday — hover over investors, Paulsen sees a “stepwise” move up to 2%.For investors, he suggests continuing to steer toward economically sensitive areas, via cyclical, small cap and international stocks. He owns technology, but is underweight as sees some underperformance ahead. “But I don’t think it’s going to crater. I think it’s going to participate in this bull.”Investors shouldn’t abandon the sector, because it has been such a domineering force throughout the globe. And down the road, he said tech companies, because they permeate so many sectors, may start to be categorized differently.What to avoid? Paulsen said he would be wary of healthcare, utilities, real-estate investment trusts, cash, bonds, gold. And yes he does see a correction likely, a big risk for this year.“I think it might come later this year but I wouldn’t be shocked, starting right now,” he said. “And that’s the biggest risk this year and I don’t think that’s a cycle ender, it certainly is painful. And I think we’re going to get one of those.”Yields are creeping up, Archegos lingersTech stocks are struggling to get a foothold in a holiday-shortened week, with futures for the Nasdaq-100 NQ00, -0.75% down. Those for the S&P 500 ES00, -0.33% and Dow YM00, -0.11% are flat to higher. But the yield on the 10-year U.S. Treasury TMUBMUSD10Y, 1.762% is up to nearly 1.77%. The Case-Shiller home price index and a gauge of consumer confidence are the data ahead.Score another for cryptocurrencies. U.S. customers of online payment provider PayPal PYPL, -2.22% can now purchase items with bitcoin BTCUSD, 3.26% and other digital assets.European stocks and banks SXXP, 0.33% are getting a breather after Monday’s selloff, led by Credit Suisse CS, -11.50%. That is as Archegos Capital Management, the U.S. fund believed to be behind the forced sale of more than $20 billion in stocks, says “all plans are being discussed.” Wall Street banks were reportedly summoned by U.S. regulators to discuss the risks and fallout.The COVID-19 vaccines from drug company Pfizer PFE, +1.02% and biotech Moderna MRNA, -7.40% stopped infections and illness in 90% of fully vaccinated people. Meanwhile, Canada has suspended the shots from drug company AstraZeneca AZN, +0.34% for adults under 55.The New York City Police Department is hunting the suspect of a vicious assault on an elderly Asian-American woman.","news_type":1},"isVote":1,"tweetType":1,"viewCount":522,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":352188278,"gmtCreate":1616907511994,"gmtModify":1704799891717,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577157678952273","authorIdStr":"3577157678952273"},"themes":[],"htmlText":"Ok ok ok","listText":"Ok ok ok","text":"Ok ok ok","images":[{"img":"https://static.tigerbbs.com/3437ad98e22ee68381fb11f71cbfa8b7","width":"1125","height":"3556"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/352188278","isVote":1,"tweetType":1,"viewCount":487,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":322111421,"gmtCreate":1615782343363,"gmtModify":1704786411153,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577157678952273","authorIdStr":"3577157678952273"},"themes":[],"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/322111421","repostId":"1108838813","repostType":4,"isVote":1,"tweetType":1,"viewCount":204,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320233894,"gmtCreate":1615110129418,"gmtModify":1704778720528,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577157678952273","authorIdStr":"3577157678952273"},"themes":[],"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/320233894","repostId":"2117639609","repostType":4,"repost":{"id":"2117639609","pubTimestamp":1614957600,"share":"https://ttm.financial/m/news/2117639609?lang=&edition=fundamental","pubTime":"2021-03-05 23:20","market":"us","language":"en","title":"What's the Outlook for Intuitive Surgical?","url":"https://stock-news.laohu8.com/highlight/detail?id=2117639609","media":"Jason Hawthorne","summary":"Competition is heating up, but the company's market leadership remains unchallenged.","content":"<p>After being relegated to science fiction for most of the 20th century, robots have been more visible over the past two decades. Although most real-world applications so far have been industrial, <b>Intuitive</b> <b>Surgical</b> (NASDAQ:ISRG) has been slowly changing that. The company's da Vinci surgical systems only assist trained humans, but they have become synonymous with the term \"robotic surgery.\"</p><p>After so much success, interested investors will want to determine whether the future can be as bright as the past, or if the combination of COVID, regulatory hurdles, and competition will chip away at the dominance this company has established since going public in 2000.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F615724%2Fgettyimages-1218322943.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>The arms of a surgical robot. Image source: Getty Images.</p><p><b>Managing through COVID-19</b></p><p>Early during the pandemic, when hospitals were stopping elective procedures to dedicate resources to patients with COVID-19, the company's sales tumbled. Year-over-year revenue declined 22% in the second quarter of 2020 on 19% fewer procedures.</p><p>Procedures and revenue rebounded slightly in the following quarter, up 7% and down 4.5%, respectively, compared to 2019. The fourth quarter finally saw year-over-year revenue growth of 4%, but management remained cautious.</p><p>Citing a holiday rise in COVID-19 cases, CEO Gary Guthart pointed to a lag in diagnostic cases at hospitals and weak surgery data spilling over from December into January as an indication that the sales of da Vinci systems would take several quarters to normalize. With fewer cases, utilization of existing machines will remain low, delaying the need to add capacity.</p><p>Although this is definitely a concern, it's a temporary <a href=\"https://laohu8.com/S/AONE\">one</a>. By the end of 2021, orders and installations should be back to normal. System growth has averaged 12% a year over the past decade and 28% for the three years prior to the pandemic. Investors are hoping the return to normal comes sooner rather than later.</p><p><b>A changing regulatory landscape</b></p><p>In recent quarters, management has become much more vocal about a shifting regulatory landscape in the U.S. and Europe, and the requirement for more data than ever before prior to approval. Guthart has said the requirements have stabilized at a level higher than in past years. Although it's a short-term nuisance, this change stands to benefit incumbents like Intuitive over time, because existing systems will sit on the market longer while innovations wait for approval.</p><p>One region where the company has drastically different regulatory experiences is Asia. Guthart has repeatedly cited South Korea as being quick to allow innovative products to market, while China's centrally managed system is more cautious. System sales in the region grew 60% from 2018 to 2019 before falling off during 2020 due to the pandemic. Products launched in China must have a longer history of performance because that country's version of the Food and Drug Administration handles first-generation products very cautiously. Regardless, the company remains excited about its joint venture with Chinese company Fosun Pharma and expects strong, if somewhat turbulent, demand over time.</p><p><b>Defending the moat</b></p><p>One of the risks in China is the launch of companies trying to bring competitive surgical systems to market. This has already happened in South Korea. That country's embrace of innovation is a double-edged sword for Intuitive -- South Korea's first approved surgical robot was made by <b>Meere</b> back in 2017.</p><p>Asia isn't the only region where companies are tired of Intuitive reaping the lion's share of the robotic surgery opportunity. Closer to home, the company faces long-awaited challenges from device makers <b>Medtronic</b> (NYSE:MDT) and <b>Johnson</b> <b>&amp;</b> <b>Johnson</b> (NYSE:JNJ).</p><p>Medtronic made its intentions clear by acquiring spine surgery innovator Mazor Robotics in 2018. It is planning a launch of its Hugo surgical system outside the U.S. to collect data, and expects to submit for an investigational device exemption from the FDA in the next month. That designation would allow the device to be used in a clinical study.</p><p>Johnson &amp; Johnson has a not-so-secret weapon in the battle for the robotic surgery market: the founder of Intuitive Surgical. Dr. Fred Moll, who practically invented the industry when he founded Intuitive in 1995, is chief development officer at the company's devices unit. With his guidance, the healthcare giant plans to commercialize three robotic platforms it gained via acquisition.</p><p>First, the Velys platform is for total knee replacements. This is the type of high-volume, repeatable procedure that is ripe for robotic assistance. But it's a threat to <b>Stryker</b> and <b>Smith</b> <b>&amp;</b> <b>Nephew</b>, not Intuitive.</p><p>Second, the Monarch platform is for a procedure that lets doctors inspect the lungs and air passages. It will eventually be used for lung biopsies, but Intuitive is already staking a claim here with its Ion system. In fact, Intuitive received FDA approval for the procedure in the first quarter of 2019.</p><p>And third, Johnson &amp; Johnson's Ottava general surgery system was introduced in November after much anticipation. The device integrates with an operating table and has six arms, several more than systems currently on the market. The goal is flexibility. If Ottava can perform many types of operations, it will help hospitals avoid buying multiple robots, each with a different purpose. The system is unlikely to come to market before 2024.</p><p><b>Clear skies, with a few clouds on the horizon</b></p><p>Despite some regulatory red tape at home and upstart competition abroad, the path for Intuitive Surgical to continue its decades of growth seems clear. The company is well ahead of the competition with nearly 6,000 surgical systems already installed around the globe, and it will be hard for competitors to replace them. That is especially true as innovation in da Vinci systems, instrumentation, and capability continues to increase both machine utilization and company sales.</p><p>As a shareholder, I'll be watching the regulatory progress of the competing systems. But changes in the approval process have only made it harder for the competition to get a foothold. With no imminent threats for at least the next few years, the shares will stay tucked away in a part of my portfolio as far from the sell button as any I own. For those looking to add the stock to their own portfolios, the recent market volatility may have provided the opportunity they've been waiting for.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What's the Outlook for Intuitive Surgical?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat's the Outlook for Intuitive Surgical?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-05 23:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/05/whats-the-outlook-for-intuitive-surgical/><strong>Jason Hawthorne</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After being relegated to science fiction for most of the 20th century, robots have been more visible over the past two decades. Although most real-world applications so far have been industrial, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/05/whats-the-outlook-for-intuitive-surgical/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F615724%2Fgettyimages-1218322943.jpg&amp;w=700&amp;op=resize","relate_stocks":{"ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2021/03/05/whats-the-outlook-for-intuitive-surgical/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2117639609","content_text":"After being relegated to science fiction for most of the 20th century, robots have been more visible over the past two decades. Although most real-world applications so far have been industrial, Intuitive Surgical (NASDAQ:ISRG) has been slowly changing that. The company's da Vinci surgical systems only assist trained humans, but they have become synonymous with the term \"robotic surgery.\"After so much success, interested investors will want to determine whether the future can be as bright as the past, or if the combination of COVID, regulatory hurdles, and competition will chip away at the dominance this company has established since going public in 2000.The arms of a surgical robot. Image source: Getty Images.Managing through COVID-19Early during the pandemic, when hospitals were stopping elective procedures to dedicate resources to patients with COVID-19, the company's sales tumbled. Year-over-year revenue declined 22% in the second quarter of 2020 on 19% fewer procedures.Procedures and revenue rebounded slightly in the following quarter, up 7% and down 4.5%, respectively, compared to 2019. The fourth quarter finally saw year-over-year revenue growth of 4%, but management remained cautious.Citing a holiday rise in COVID-19 cases, CEO Gary Guthart pointed to a lag in diagnostic cases at hospitals and weak surgery data spilling over from December into January as an indication that the sales of da Vinci systems would take several quarters to normalize. With fewer cases, utilization of existing machines will remain low, delaying the need to add capacity.Although this is definitely a concern, it's a temporary one. By the end of 2021, orders and installations should be back to normal. System growth has averaged 12% a year over the past decade and 28% for the three years prior to the pandemic. Investors are hoping the return to normal comes sooner rather than later.A changing regulatory landscapeIn recent quarters, management has become much more vocal about a shifting regulatory landscape in the U.S. and Europe, and the requirement for more data than ever before prior to approval. Guthart has said the requirements have stabilized at a level higher than in past years. Although it's a short-term nuisance, this change stands to benefit incumbents like Intuitive over time, because existing systems will sit on the market longer while innovations wait for approval.One region where the company has drastically different regulatory experiences is Asia. Guthart has repeatedly cited South Korea as being quick to allow innovative products to market, while China's centrally managed system is more cautious. System sales in the region grew 60% from 2018 to 2019 before falling off during 2020 due to the pandemic. Products launched in China must have a longer history of performance because that country's version of the Food and Drug Administration handles first-generation products very cautiously. Regardless, the company remains excited about its joint venture with Chinese company Fosun Pharma and expects strong, if somewhat turbulent, demand over time.Defending the moatOne of the risks in China is the launch of companies trying to bring competitive surgical systems to market. This has already happened in South Korea. That country's embrace of innovation is a double-edged sword for Intuitive -- South Korea's first approved surgical robot was made by Meere back in 2017.Asia isn't the only region where companies are tired of Intuitive reaping the lion's share of the robotic surgery opportunity. Closer to home, the company faces long-awaited challenges from device makers Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ).Medtronic made its intentions clear by acquiring spine surgery innovator Mazor Robotics in 2018. It is planning a launch of its Hugo surgical system outside the U.S. to collect data, and expects to submit for an investigational device exemption from the FDA in the next month. That designation would allow the device to be used in a clinical study.Johnson & Johnson has a not-so-secret weapon in the battle for the robotic surgery market: the founder of Intuitive Surgical. Dr. Fred Moll, who practically invented the industry when he founded Intuitive in 1995, is chief development officer at the company's devices unit. With his guidance, the healthcare giant plans to commercialize three robotic platforms it gained via acquisition.First, the Velys platform is for total knee replacements. This is the type of high-volume, repeatable procedure that is ripe for robotic assistance. But it's a threat to Stryker and Smith & Nephew, not Intuitive.Second, the Monarch platform is for a procedure that lets doctors inspect the lungs and air passages. It will eventually be used for lung biopsies, but Intuitive is already staking a claim here with its Ion system. In fact, Intuitive received FDA approval for the procedure in the first quarter of 2019.And third, Johnson & Johnson's Ottava general surgery system was introduced in November after much anticipation. The device integrates with an operating table and has six arms, several more than systems currently on the market. The goal is flexibility. If Ottava can perform many types of operations, it will help hospitals avoid buying multiple robots, each with a different purpose. The system is unlikely to come to market before 2024.Clear skies, with a few clouds on the horizonDespite some regulatory red tape at home and upstart competition abroad, the path for Intuitive Surgical to continue its decades of growth seems clear. The company is well ahead of the competition with nearly 6,000 surgical systems already installed around the globe, and it will be hard for competitors to replace them. That is especially true as innovation in da Vinci systems, instrumentation, and capability continues to increase both machine utilization and company sales.As a shareholder, I'll be watching the regulatory progress of the competing systems. But changes in the approval process have only made it harder for the competition to get a foothold. With no imminent threats for at least the next few years, the shares will stay tucked away in a part of my portfolio as far from the sell button as any I own. For those looking to add the stock to their own portfolios, the recent market volatility may have provided the opportunity they've been waiting for.","news_type":1},"isVote":1,"tweetType":1,"viewCount":327,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320233921,"gmtCreate":1615110093963,"gmtModify":1704778720039,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577157678952273","authorIdStr":"3577157678952273"},"themes":[],"htmlText":"........","listText":"........","text":"........","images":[{"img":"https://static.tigerbbs.com/760477c6fb49af73d085ea0327019170","width":"1125","height":"3114"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/320233921","isVote":1,"tweetType":1,"viewCount":371,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":366138611,"gmtCreate":1614406966433,"gmtModify":1704771625232,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3577157678952273","authorIdStr":"3577157678952273"},"themes":[],"htmlText":"Is this for long term?","listText":"Is this for long term?","text":"Is this for long term?","images":[{"img":"https://static.tigerbbs.com/2eda99c6844e002795f702b350c203aa","width":"1125","height":"3070"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/366138611","isVote":1,"tweetType":1,"viewCount":128,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":354857401,"gmtCreate":1617161179103,"gmtModify":1704696617725,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577157678952273","idStr":"3577157678952273"},"themes":[],"htmlText":"Comment and like","listText":"Comment and like","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/354857401","repostId":"1163996400","repostType":4,"repost":{"id":"1163996400","pubTimestamp":1617094880,"share":"https://ttm.financial/m/news/1163996400?lang=&edition=fundamental","pubTime":"2021-03-30 17:01","market":"us","language":"en","title":"Coursera: The Education Disruptor Goes Public","url":"https://stock-news.laohu8.com/highlight/detail?id=1163996400","media":"seekingalpha","summary":"SummaryThe company is growing rapidly as a result of secular trends as well as the Covid-19 pandemic","content":"<p><b>Summary</b></p><ul><li>The company is growing rapidly as a result of secular trends as well as the Covid-19 pandemic.</li><li>It is operating in a huge addressable market that is likely to grow for the foreseeable future.</li><li>Coursera enjoys many competitive advantages, among them a large, existing user base, price-to-cost advantages, and the ability to personalize content as a result of its trove of data.</li><li>Given its scale, and competitive advantages, the company should win an outsized share of its market opportunity.</li><li>However, because the company has not turned a profit, there is a chance that its stock may be too volatile in the near term. Buying when the company turns a profit is the safer bet.</li></ul><p>Coursera (COURS), the online learning platform founded in 2012 by former Stanford University computer science professors Daphne Koller and Andrew Ng, filed itsIPO prospectuswith the Securities and Exchange Commission (SEC). The Mountain View, California-based company offers individuals access to over 4,000 Massive Open Online Courses (MOOCs) from 200 educational institutions and corporations. The company also offers over two dozen degree programs at prices lower than what a learner would pay at a traditional, in-person institution. As the company grows its offering, it will be able to compete head-to-head with other “online program management” (OPM) providers, such as 2U(NASDAQ:TWOU), which is already publicly traded, and Noodle Partners.</p><p>Ng’sshareholder letter in the S-1articulated clearly just what the company is about:</p><blockquote>“We believe that education is the source of human progress. In today’s economy in which the skills needed to succeed are rapidly evolving, education is becoming more important than ever. As automation and digital disruption are poised to replace unprecedented numbers of jobs worldwide, giving workers the opportunity to upskill and reskill will be crucial to raising global living standards and increasing social equity. Online education will play a critical role, enabling anyone, anywhere, to gain the valuable skills they need to earn a living in an increasingly digital economy.”</blockquote><p>The filing lists Morgan Stanley, Goldman Sachs and Citigroup as underwriters. The number of shares and the price range of the proposed offering are yet to be determined.According to PitchBook data, Coursera’s most recent valuation in the private markets was $2.5 billion. To date, the company has raised $464 million in venture capital, most recently,$130 million in a Series F roundlast July. Coursera’s biggest institutional shareholders are New Enterprise Associates (18.3% of company stock), G Squared (15.9%) and Kleiner Perkins (9.2%).</p><p><b>Operating Results</b></p><p>The company earned $293 million in revenues for the fiscal year ended December 31, 2020, up 59% from 2019. Net losses widened by about $20 million year-on-year, reaching $66.8 million in 2020. Revenues shot up as a result of the Covid-19 pandemic’s effect on traditional education. In tandem with rising demand, operating costs associated with the company’s services rose, largely driven by the freemium content and marketing expenses. Coursera added over 12,000 new degree learners across the two years ended December 31, 2020 at an average acquisition cost of just below $2,000. The number of registered users rose by 65% year-on-year in 2020. Coursera’s accumulated deficit since its founding stood at $343.6 million as of December 31, 2020. The company does not expect to turn a profit in the foreseeable future.</p><p>The company’sCoursera for Campus,launched in late 2019to enable colleges to offer its library of MOOCs to their students, has been a key driver of recent revenue growth. At the start of the pandemic, Coursera made the program free to tertiary institutions until Sept. 30, 2020. Over 4,000 tertiary institutions from across the world signed up for the program, which, according to the company’s S-1 filing, makes it, “one of our fastest growing offerings”. As of December 31, 2020, over 130 tertiary institutions were paying for it.</p><p>At this point, it is hard to predict what the end of the pandemic would have on the company’s operating results.</p><p><b>The Strategy and Market Opportunity</b></p><p>Coursera is one of the most disruptive firms in the world. It has a flywheel approach to value creation, with significant price-to-cost advantages versus its competition. The company reported that about half of its new degree students in 2020 had been previously registered with Coursera and that its average student acquisition cost was less than $2,000. Its average student acquisition cost is lower than the industry standard. The edu-tech platform is able to efficiently acquire learners at scale because of the huge number of free, high-quality courses that it offers in partnership with top educational institutions and corporations; its ability to personalize content based on its wealth of data; the strength of word-of-mouth promotion by learners; the profitability of its affiliate paid marketing channel.</p><p>The platform offers a number of education tracks, for example:</p><ul><li>Specializations: A learner can pay between $39 and $99 a month for job-specific content across over 500 categories.</li><li>MasterTrack Certificates: For a quarter to a year, a learner can earn a certificate issued by a university-issued certificate. Prices range from $2,000 to $6,000.</li><li>Bachelor’s or Master’s Degrees: Fees range from $9,000 to $45,000.</li><li>Coursera for Enterprise: Through this platform, businesses, educational institutions and governments can deploy content to their learners.</li></ul><p>In response to the Covid-19 pandemic, Coursera partnered with over 330 government agencies across 30 U.S. states and cities and 70 countries as part of itsCoursera Workforce Recovery Initiative, which gave governments the chance to offer unemployed workers free access to thousands of business, data science, and technology courses from companies such as Amazon(NASDAQ:AMZN)and Google(NASDAQ:GOOG)(NASDAQ:GOOGL).</p><p>The company has 77 million registered learners, as well as over 2,000 businesses (including 25% of Fortune 500 companies) and 100 government agencies who paid for its enterprise offerings. The majority of its revenue (51%) was earned outside of the United States. Converting only a fraction of its 77 million registered users into paid users would change the economics of customer acquisition. The company’s present scale is a huge competitive advantage in the market.</p><p>A learner’s curriculum is designed to be “stackable”, which is to say that a learner can go through a domain in an incremental fashion. The company is able to leverage the huge volume of data it has accumulated from its over 220 million enrollments to personalize content. So, for example, Coursera’s Skills Graphs can suggest paths for job skills.</p><p>Coursera uses technology to drive down distribution costs, make content more affordable, extend access to less economically-endowed regions, help learners keep abreast of emerging skills, and grow its market opportunity. The Covid-19 pandemic has only accelerated secular trends towards the use of technology in education.</p><p>The size of the addressable market is massive and it’s easy to see why.An August 2020 study by the United Nationsdemonstrates the degree of disruption brought on by the Covid-19 pandemic: of the 1.6 billion students in 190 countries covered in the report, or 94% of the world’s students, were prevented from going to school because of Covid-19 pandemic related school closures.</p><p>In 2017, the World Bank indicated thatof the 200 million college students in the world, many do not have job-specific skills.</p><p>The Covid-19 pandemic and prior secular trends suggest that the future of education is in blended classrooms, job-specific education and continuous, lifelong education. Online learning platforms like Coursera will be the primary means through which educational content is delivered.</p><p>Globally, spending on higher education in 2019 was $2.2 trillion,according to HolonIQ. Spending on online degrees was $36 billion and is predicted to reach $74 billion by 2025.</p><p>With a huge, existing learner base; a strong brand; and the significant advantages detailed above, Coursera is likely to grab a significant amount of the market’s growth. Of thescenarios for the future of education, it seems that Coursera will continue to grow.</p><p><b>Conclusion</b></p><p>Coursera seems poised to meet the challenges of a changing education landscape. With its vast, existing user base, its flywheel model, its competitive advantages, and its existence in a huge and growing addressable market, the company is likely to do very well. The company’s value proposition is compelling. However, long run success does not equate to a good investment in the short run. An unprofitable company like Coursera is likely to be very volatile on the markets until it reaches profitability. It is better to wait for Coursera to turn a profit before investing in the company.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Coursera: The Education Disruptor Goes Public</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCoursera: The Education Disruptor Goes Public\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-30 17:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4413745-coursera-education-disruptor-goes-public><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryThe company is growing rapidly as a result of secular trends as well as the Covid-19 pandemic.It is operating in a huge addressable market that is likely to grow for the foreseeable future....</p>\n\n<a href=\"https://seekingalpha.com/article/4413745-coursera-education-disruptor-goes-public\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/7cedd6cbf23bbe97eaec389fb0773ed6","relate_stocks":{"COUR":"Coursera, Inc."},"source_url":"https://seekingalpha.com/article/4413745-coursera-education-disruptor-goes-public","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1163996400","content_text":"SummaryThe company is growing rapidly as a result of secular trends as well as the Covid-19 pandemic.It is operating in a huge addressable market that is likely to grow for the foreseeable future.Coursera enjoys many competitive advantages, among them a large, existing user base, price-to-cost advantages, and the ability to personalize content as a result of its trove of data.Given its scale, and competitive advantages, the company should win an outsized share of its market opportunity.However, because the company has not turned a profit, there is a chance that its stock may be too volatile in the near term. Buying when the company turns a profit is the safer bet.Coursera (COURS), the online learning platform founded in 2012 by former Stanford University computer science professors Daphne Koller and Andrew Ng, filed itsIPO prospectuswith the Securities and Exchange Commission (SEC). The Mountain View, California-based company offers individuals access to over 4,000 Massive Open Online Courses (MOOCs) from 200 educational institutions and corporations. The company also offers over two dozen degree programs at prices lower than what a learner would pay at a traditional, in-person institution. As the company grows its offering, it will be able to compete head-to-head with other “online program management” (OPM) providers, such as 2U(NASDAQ:TWOU), which is already publicly traded, and Noodle Partners.Ng’sshareholder letter in the S-1articulated clearly just what the company is about:“We believe that education is the source of human progress. In today’s economy in which the skills needed to succeed are rapidly evolving, education is becoming more important than ever. As automation and digital disruption are poised to replace unprecedented numbers of jobs worldwide, giving workers the opportunity to upskill and reskill will be crucial to raising global living standards and increasing social equity. Online education will play a critical role, enabling anyone, anywhere, to gain the valuable skills they need to earn a living in an increasingly digital economy.”The filing lists Morgan Stanley, Goldman Sachs and Citigroup as underwriters. The number of shares and the price range of the proposed offering are yet to be determined.According to PitchBook data, Coursera’s most recent valuation in the private markets was $2.5 billion. To date, the company has raised $464 million in venture capital, most recently,$130 million in a Series F roundlast July. Coursera’s biggest institutional shareholders are New Enterprise Associates (18.3% of company stock), G Squared (15.9%) and Kleiner Perkins (9.2%).Operating ResultsThe company earned $293 million in revenues for the fiscal year ended December 31, 2020, up 59% from 2019. Net losses widened by about $20 million year-on-year, reaching $66.8 million in 2020. Revenues shot up as a result of the Covid-19 pandemic’s effect on traditional education. In tandem with rising demand, operating costs associated with the company’s services rose, largely driven by the freemium content and marketing expenses. Coursera added over 12,000 new degree learners across the two years ended December 31, 2020 at an average acquisition cost of just below $2,000. The number of registered users rose by 65% year-on-year in 2020. Coursera’s accumulated deficit since its founding stood at $343.6 million as of December 31, 2020. The company does not expect to turn a profit in the foreseeable future.The company’sCoursera for Campus,launched in late 2019to enable colleges to offer its library of MOOCs to their students, has been a key driver of recent revenue growth. At the start of the pandemic, Coursera made the program free to tertiary institutions until Sept. 30, 2020. Over 4,000 tertiary institutions from across the world signed up for the program, which, according to the company’s S-1 filing, makes it, “one of our fastest growing offerings”. As of December 31, 2020, over 130 tertiary institutions were paying for it.At this point, it is hard to predict what the end of the pandemic would have on the company’s operating results.The Strategy and Market OpportunityCoursera is one of the most disruptive firms in the world. It has a flywheel approach to value creation, with significant price-to-cost advantages versus its competition. The company reported that about half of its new degree students in 2020 had been previously registered with Coursera and that its average student acquisition cost was less than $2,000. Its average student acquisition cost is lower than the industry standard. The edu-tech platform is able to efficiently acquire learners at scale because of the huge number of free, high-quality courses that it offers in partnership with top educational institutions and corporations; its ability to personalize content based on its wealth of data; the strength of word-of-mouth promotion by learners; the profitability of its affiliate paid marketing channel.The platform offers a number of education tracks, for example:Specializations: A learner can pay between $39 and $99 a month for job-specific content across over 500 categories.MasterTrack Certificates: For a quarter to a year, a learner can earn a certificate issued by a university-issued certificate. Prices range from $2,000 to $6,000.Bachelor’s or Master’s Degrees: Fees range from $9,000 to $45,000.Coursera for Enterprise: Through this platform, businesses, educational institutions and governments can deploy content to their learners.In response to the Covid-19 pandemic, Coursera partnered with over 330 government agencies across 30 U.S. states and cities and 70 countries as part of itsCoursera Workforce Recovery Initiative, which gave governments the chance to offer unemployed workers free access to thousands of business, data science, and technology courses from companies such as Amazon(NASDAQ:AMZN)and Google(NASDAQ:GOOG)(NASDAQ:GOOGL).The company has 77 million registered learners, as well as over 2,000 businesses (including 25% of Fortune 500 companies) and 100 government agencies who paid for its enterprise offerings. The majority of its revenue (51%) was earned outside of the United States. Converting only a fraction of its 77 million registered users into paid users would change the economics of customer acquisition. The company’s present scale is a huge competitive advantage in the market.A learner’s curriculum is designed to be “stackable”, which is to say that a learner can go through a domain in an incremental fashion. The company is able to leverage the huge volume of data it has accumulated from its over 220 million enrollments to personalize content. So, for example, Coursera’s Skills Graphs can suggest paths for job skills.Coursera uses technology to drive down distribution costs, make content more affordable, extend access to less economically-endowed regions, help learners keep abreast of emerging skills, and grow its market opportunity. The Covid-19 pandemic has only accelerated secular trends towards the use of technology in education.The size of the addressable market is massive and it’s easy to see why.An August 2020 study by the United Nationsdemonstrates the degree of disruption brought on by the Covid-19 pandemic: of the 1.6 billion students in 190 countries covered in the report, or 94% of the world’s students, were prevented from going to school because of Covid-19 pandemic related school closures.In 2017, the World Bank indicated thatof the 200 million college students in the world, many do not have job-specific skills.The Covid-19 pandemic and prior secular trends suggest that the future of education is in blended classrooms, job-specific education and continuous, lifelong education. Online learning platforms like Coursera will be the primary means through which educational content is delivered.Globally, spending on higher education in 2019 was $2.2 trillion,according to HolonIQ. Spending on online degrees was $36 billion and is predicted to reach $74 billion by 2025.With a huge, existing learner base; a strong brand; and the significant advantages detailed above, Coursera is likely to grab a significant amount of the market’s growth. Of thescenarios for the future of education, it seems that Coursera will continue to grow.ConclusionCoursera seems poised to meet the challenges of a changing education landscape. With its vast, existing user base, its flywheel model, its competitive advantages, and its existence in a huge and growing addressable market, the company is likely to do very well. The company’s value proposition is compelling. However, long run success does not equate to a good investment in the short run. An unprofitable company like Coursera is likely to be very volatile on the markets until it reaches profitability. It is better to wait for Coursera to turn a profit before investing in the company.","news_type":1},"isVote":1,"tweetType":1,"viewCount":353,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":349210777,"gmtCreate":1617614458399,"gmtModify":1704700850787,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577157678952273","idStr":"3577157678952273"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/349210777","repostId":"2125768475","repostType":4,"repost":{"id":"2125768475","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1617614291,"share":"https://ttm.financial/m/news/2125768475?lang=&edition=fundamental","pubTime":"2021-04-05 17:18","market":"hk","language":"en","title":"5 Stocks To Watch For April 5, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2125768475","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:","content":"<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li><b>Tesla Inc </b> (NASDAQ:TSLA) reported that it has delivered 184,800 vehicles in the first quarter, handily exceeding the 168,000 number analysts expected. Tesla shares gained 5.3% to $697.11 in pre-market trading.</li>\n <li><b>$Bank of America Corp(BAC-N)$</b> (NYSE:BAC) announced the acquisition of Axia Technologies, Inc., a health care payment and technology firm focused on facilitating secure patient payments. The bank is expected to release quarterly earnings on April 15. Bank of America shares rose 2.1% to close at $39.49 on Thursday.</li>\n <li>Wall Street expects <b> <a href=\"https://laohu8.com/S/DCT\">Duck Creek Technologies, Inc.</a></b> (NASDAQ:DCT) to post a quarterly loss at $0.03 per share on revenue of $59.20 million after the closing bell. Duck Creek Technologies shares fell 0.4% to close at $44.96 on Thursday.</li>\n</ul>\n<ul>\n <li><b>Franklin Covey Co. </b> (NYSE:FC) reported a narrower-than-expected loss for its second quarter, while sales missed estimates. Franklin Covey shares gained 3.5% to close at $ $29.35 on Thursday.</li>\n <li><b><a href=\"https://laohu8.com/S/IEPRR\">Icahn Enterprises LP</a></b> (NASDAQ:IEP) named former GE executive Aris Kekedjian as its CEO, the Wall Street Journal reported. Icahn Enterprises shares rose 2.5% to close at $55.05 on Thursday.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For April 5, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For April 5, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-04-05 17:18</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li><b>Tesla Inc </b> (NASDAQ:TSLA) reported that it has delivered 184,800 vehicles in the first quarter, handily exceeding the 168,000 number analysts expected. Tesla shares gained 5.3% to $697.11 in pre-market trading.</li>\n <li><b>$Bank of America Corp(BAC-N)$</b> (NYSE:BAC) announced the acquisition of Axia Technologies, Inc., a health care payment and technology firm focused on facilitating secure patient payments. The bank is expected to release quarterly earnings on April 15. Bank of America shares rose 2.1% to close at $39.49 on Thursday.</li>\n <li>Wall Street expects <b> <a href=\"https://laohu8.com/S/DCT\">Duck Creek Technologies, Inc.</a></b> (NASDAQ:DCT) to post a quarterly loss at $0.03 per share on revenue of $59.20 million after the closing bell. Duck Creek Technologies shares fell 0.4% to close at $44.96 on Thursday.</li>\n</ul>\n<ul>\n <li><b>Franklin Covey Co. </b> (NYSE:FC) reported a narrower-than-expected loss for its second quarter, while sales missed estimates. Franklin Covey shares gained 3.5% to close at $ $29.35 on Thursday.</li>\n <li><b><a href=\"https://laohu8.com/S/IEPRR\">Icahn Enterprises LP</a></b> (NASDAQ:IEP) named former GE executive Aris Kekedjian as its CEO, the Wall Street Journal reported. Icahn Enterprises shares rose 2.5% to close at $55.05 on Thursday.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","FC":"富兰克林柯维","IEP":"伊坎企业","BAC":"美国银行"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2125768475","content_text":"Some of the stocks that may grab investor focus today are:\n\nTesla Inc  (NASDAQ:TSLA) reported that it has delivered 184,800 vehicles in the first quarter, handily exceeding the 168,000 number analysts expected. Tesla shares gained 5.3% to $697.11 in pre-market trading.\n$Bank of America Corp(BAC-N)$ (NYSE:BAC) announced the acquisition of Axia Technologies, Inc., a health care payment and technology firm focused on facilitating secure patient payments. The bank is expected to release quarterly earnings on April 15. Bank of America shares rose 2.1% to close at $39.49 on Thursday.\nWall Street expects  Duck Creek Technologies, Inc. (NASDAQ:DCT) to post a quarterly loss at $0.03 per share on revenue of $59.20 million after the closing bell. Duck Creek Technologies shares fell 0.4% to close at $44.96 on Thursday.\n\n\nFranklin Covey Co.  (NYSE:FC) reported a narrower-than-expected loss for its second quarter, while sales missed estimates. Franklin Covey shares gained 3.5% to close at $ $29.35 on Thursday.\nIcahn Enterprises LP (NASDAQ:IEP) named former GE executive Aris Kekedjian as its CEO, the Wall Street Journal reported. Icahn Enterprises shares rose 2.5% to close at $55.05 on Thursday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":362,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":355716840,"gmtCreate":1617104867480,"gmtModify":1704695868609,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577157678952273","idStr":"3577157678952273"},"themes":[],"htmlText":"Comment and like","listText":"Comment and like","text":"Comment and like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/355716840","repostId":"1162058288","repostType":4,"isVote":1,"tweetType":1,"viewCount":522,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320233894,"gmtCreate":1615110129418,"gmtModify":1704778720528,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577157678952273","idStr":"3577157678952273"},"themes":[],"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/320233894","repostId":"2117639609","repostType":4,"repost":{"id":"2117639609","pubTimestamp":1614957600,"share":"https://ttm.financial/m/news/2117639609?lang=&edition=fundamental","pubTime":"2021-03-05 23:20","market":"us","language":"en","title":"What's the Outlook for Intuitive Surgical?","url":"https://stock-news.laohu8.com/highlight/detail?id=2117639609","media":"Jason Hawthorne","summary":"Competition is heating up, but the company's market leadership remains unchallenged.","content":"<p>After being relegated to science fiction for most of the 20th century, robots have been more visible over the past two decades. Although most real-world applications so far have been industrial, <b>Intuitive</b> <b>Surgical</b> (NASDAQ:ISRG) has been slowly changing that. The company's da Vinci surgical systems only assist trained humans, but they have become synonymous with the term \"robotic surgery.\"</p><p>After so much success, interested investors will want to determine whether the future can be as bright as the past, or if the combination of COVID, regulatory hurdles, and competition will chip away at the dominance this company has established since going public in 2000.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F615724%2Fgettyimages-1218322943.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>The arms of a surgical robot. Image source: Getty Images.</p><p><b>Managing through COVID-19</b></p><p>Early during the pandemic, when hospitals were stopping elective procedures to dedicate resources to patients with COVID-19, the company's sales tumbled. Year-over-year revenue declined 22% in the second quarter of 2020 on 19% fewer procedures.</p><p>Procedures and revenue rebounded slightly in the following quarter, up 7% and down 4.5%, respectively, compared to 2019. The fourth quarter finally saw year-over-year revenue growth of 4%, but management remained cautious.</p><p>Citing a holiday rise in COVID-19 cases, CEO Gary Guthart pointed to a lag in diagnostic cases at hospitals and weak surgery data spilling over from December into January as an indication that the sales of da Vinci systems would take several quarters to normalize. With fewer cases, utilization of existing machines will remain low, delaying the need to add capacity.</p><p>Although this is definitely a concern, it's a temporary <a href=\"https://laohu8.com/S/AONE\">one</a>. By the end of 2021, orders and installations should be back to normal. System growth has averaged 12% a year over the past decade and 28% for the three years prior to the pandemic. Investors are hoping the return to normal comes sooner rather than later.</p><p><b>A changing regulatory landscape</b></p><p>In recent quarters, management has become much more vocal about a shifting regulatory landscape in the U.S. and Europe, and the requirement for more data than ever before prior to approval. Guthart has said the requirements have stabilized at a level higher than in past years. Although it's a short-term nuisance, this change stands to benefit incumbents like Intuitive over time, because existing systems will sit on the market longer while innovations wait for approval.</p><p>One region where the company has drastically different regulatory experiences is Asia. Guthart has repeatedly cited South Korea as being quick to allow innovative products to market, while China's centrally managed system is more cautious. System sales in the region grew 60% from 2018 to 2019 before falling off during 2020 due to the pandemic. Products launched in China must have a longer history of performance because that country's version of the Food and Drug Administration handles first-generation products very cautiously. Regardless, the company remains excited about its joint venture with Chinese company Fosun Pharma and expects strong, if somewhat turbulent, demand over time.</p><p><b>Defending the moat</b></p><p>One of the risks in China is the launch of companies trying to bring competitive surgical systems to market. This has already happened in South Korea. That country's embrace of innovation is a double-edged sword for Intuitive -- South Korea's first approved surgical robot was made by <b>Meere</b> back in 2017.</p><p>Asia isn't the only region where companies are tired of Intuitive reaping the lion's share of the robotic surgery opportunity. Closer to home, the company faces long-awaited challenges from device makers <b>Medtronic</b> (NYSE:MDT) and <b>Johnson</b> <b>&amp;</b> <b>Johnson</b> (NYSE:JNJ).</p><p>Medtronic made its intentions clear by acquiring spine surgery innovator Mazor Robotics in 2018. It is planning a launch of its Hugo surgical system outside the U.S. to collect data, and expects to submit for an investigational device exemption from the FDA in the next month. That designation would allow the device to be used in a clinical study.</p><p>Johnson &amp; Johnson has a not-so-secret weapon in the battle for the robotic surgery market: the founder of Intuitive Surgical. Dr. Fred Moll, who practically invented the industry when he founded Intuitive in 1995, is chief development officer at the company's devices unit. With his guidance, the healthcare giant plans to commercialize three robotic platforms it gained via acquisition.</p><p>First, the Velys platform is for total knee replacements. This is the type of high-volume, repeatable procedure that is ripe for robotic assistance. But it's a threat to <b>Stryker</b> and <b>Smith</b> <b>&amp;</b> <b>Nephew</b>, not Intuitive.</p><p>Second, the Monarch platform is for a procedure that lets doctors inspect the lungs and air passages. It will eventually be used for lung biopsies, but Intuitive is already staking a claim here with its Ion system. In fact, Intuitive received FDA approval for the procedure in the first quarter of 2019.</p><p>And third, Johnson &amp; Johnson's Ottava general surgery system was introduced in November after much anticipation. The device integrates with an operating table and has six arms, several more than systems currently on the market. The goal is flexibility. If Ottava can perform many types of operations, it will help hospitals avoid buying multiple robots, each with a different purpose. The system is unlikely to come to market before 2024.</p><p><b>Clear skies, with a few clouds on the horizon</b></p><p>Despite some regulatory red tape at home and upstart competition abroad, the path for Intuitive Surgical to continue its decades of growth seems clear. The company is well ahead of the competition with nearly 6,000 surgical systems already installed around the globe, and it will be hard for competitors to replace them. That is especially true as innovation in da Vinci systems, instrumentation, and capability continues to increase both machine utilization and company sales.</p><p>As a shareholder, I'll be watching the regulatory progress of the competing systems. But changes in the approval process have only made it harder for the competition to get a foothold. With no imminent threats for at least the next few years, the shares will stay tucked away in a part of my portfolio as far from the sell button as any I own. For those looking to add the stock to their own portfolios, the recent market volatility may have provided the opportunity they've been waiting for.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What's the Outlook for Intuitive Surgical?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat's the Outlook for Intuitive Surgical?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-05 23:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/05/whats-the-outlook-for-intuitive-surgical/><strong>Jason Hawthorne</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After being relegated to science fiction for most of the 20th century, robots have been more visible over the past two decades. Although most real-world applications so far have been industrial, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/05/whats-the-outlook-for-intuitive-surgical/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F615724%2Fgettyimages-1218322943.jpg&amp;w=700&amp;op=resize","relate_stocks":{"ISRG":"直觉外科公司"},"source_url":"https://www.fool.com/investing/2021/03/05/whats-the-outlook-for-intuitive-surgical/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2117639609","content_text":"After being relegated to science fiction for most of the 20th century, robots have been more visible over the past two decades. Although most real-world applications so far have been industrial, Intuitive Surgical (NASDAQ:ISRG) has been slowly changing that. The company's da Vinci surgical systems only assist trained humans, but they have become synonymous with the term \"robotic surgery.\"After so much success, interested investors will want to determine whether the future can be as bright as the past, or if the combination of COVID, regulatory hurdles, and competition will chip away at the dominance this company has established since going public in 2000.The arms of a surgical robot. Image source: Getty Images.Managing through COVID-19Early during the pandemic, when hospitals were stopping elective procedures to dedicate resources to patients with COVID-19, the company's sales tumbled. Year-over-year revenue declined 22% in the second quarter of 2020 on 19% fewer procedures.Procedures and revenue rebounded slightly in the following quarter, up 7% and down 4.5%, respectively, compared to 2019. The fourth quarter finally saw year-over-year revenue growth of 4%, but management remained cautious.Citing a holiday rise in COVID-19 cases, CEO Gary Guthart pointed to a lag in diagnostic cases at hospitals and weak surgery data spilling over from December into January as an indication that the sales of da Vinci systems would take several quarters to normalize. With fewer cases, utilization of existing machines will remain low, delaying the need to add capacity.Although this is definitely a concern, it's a temporary one. By the end of 2021, orders and installations should be back to normal. System growth has averaged 12% a year over the past decade and 28% for the three years prior to the pandemic. Investors are hoping the return to normal comes sooner rather than later.A changing regulatory landscapeIn recent quarters, management has become much more vocal about a shifting regulatory landscape in the U.S. and Europe, and the requirement for more data than ever before prior to approval. Guthart has said the requirements have stabilized at a level higher than in past years. Although it's a short-term nuisance, this change stands to benefit incumbents like Intuitive over time, because existing systems will sit on the market longer while innovations wait for approval.One region where the company has drastically different regulatory experiences is Asia. Guthart has repeatedly cited South Korea as being quick to allow innovative products to market, while China's centrally managed system is more cautious. System sales in the region grew 60% from 2018 to 2019 before falling off during 2020 due to the pandemic. Products launched in China must have a longer history of performance because that country's version of the Food and Drug Administration handles first-generation products very cautiously. Regardless, the company remains excited about its joint venture with Chinese company Fosun Pharma and expects strong, if somewhat turbulent, demand over time.Defending the moatOne of the risks in China is the launch of companies trying to bring competitive surgical systems to market. This has already happened in South Korea. That country's embrace of innovation is a double-edged sword for Intuitive -- South Korea's first approved surgical robot was made by Meere back in 2017.Asia isn't the only region where companies are tired of Intuitive reaping the lion's share of the robotic surgery opportunity. Closer to home, the company faces long-awaited challenges from device makers Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ).Medtronic made its intentions clear by acquiring spine surgery innovator Mazor Robotics in 2018. It is planning a launch of its Hugo surgical system outside the U.S. to collect data, and expects to submit for an investigational device exemption from the FDA in the next month. That designation would allow the device to be used in a clinical study.Johnson & Johnson has a not-so-secret weapon in the battle for the robotic surgery market: the founder of Intuitive Surgical. Dr. Fred Moll, who practically invented the industry when he founded Intuitive in 1995, is chief development officer at the company's devices unit. With his guidance, the healthcare giant plans to commercialize three robotic platforms it gained via acquisition.First, the Velys platform is for total knee replacements. This is the type of high-volume, repeatable procedure that is ripe for robotic assistance. But it's a threat to Stryker and Smith & Nephew, not Intuitive.Second, the Monarch platform is for a procedure that lets doctors inspect the lungs and air passages. It will eventually be used for lung biopsies, but Intuitive is already staking a claim here with its Ion system. In fact, Intuitive received FDA approval for the procedure in the first quarter of 2019.And third, Johnson & Johnson's Ottava general surgery system was introduced in November after much anticipation. The device integrates with an operating table and has six arms, several more than systems currently on the market. The goal is flexibility. If Ottava can perform many types of operations, it will help hospitals avoid buying multiple robots, each with a different purpose. The system is unlikely to come to market before 2024.Clear skies, with a few clouds on the horizonDespite some regulatory red tape at home and upstart competition abroad, the path for Intuitive Surgical to continue its decades of growth seems clear. The company is well ahead of the competition with nearly 6,000 surgical systems already installed around the globe, and it will be hard for competitors to replace them. That is especially true as innovation in da Vinci systems, instrumentation, and capability continues to increase both machine utilization and company sales.As a shareholder, I'll be watching the regulatory progress of the competing systems. But changes in the approval process have only made it harder for the competition to get a foothold. With no imminent threats for at least the next few years, the shares will stay tucked away in a part of my portfolio as far from the sell button as any I own. For those looking to add the stock to their own portfolios, the recent market volatility may have provided the opportunity they've been waiting for.","news_type":1},"isVote":1,"tweetType":1,"viewCount":327,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":354849386,"gmtCreate":1617161278145,"gmtModify":1704696618208,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577157678952273","idStr":"3577157678952273"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/354849386","repostId":"1182614778","repostType":4,"isVote":1,"tweetType":1,"viewCount":415,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":322111421,"gmtCreate":1615782343363,"gmtModify":1704786411153,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577157678952273","idStr":"3577157678952273"},"themes":[],"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/322111421","repostId":"1108838813","repostType":4,"repost":{"id":"1108838813","pubTimestamp":1615780854,"share":"https://ttm.financial/m/news/1108838813?lang=&edition=fundamental","pubTime":"2021-03-15 12:00","market":"us","language":"en","title":"Koss: Don't Buy The Hype On This Highly Shorted Meme Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1108838813","media":"seekingalpha","summary":"Summary\n\nKoss is a small electronics company that got caught up in the meme stock runup, but has lit","content":"<p><b>Summary</b></p>\n<ul>\n <li>Koss is a small electronics company that got caught up in the meme stock runup, but has little hope for massive growth in the future.</li>\n <li>Meme stocks trade on hype instead of fundamentals, so be careful not to lose your shirt.</li>\n <li>Koss offers massive upside during the next short squeeze, but should be avoided as a long-term investment.</li>\n</ul>\n<p>Koss(NASDAQ:KOSS)is a headphone and electronic accessories company that has gotten a lot of attention recently due to the rise of \"Meme Stocks\" like GameStop (GME) and AMC (AMC).</p>\n<p>Retail traders began focusing on stocks with low float and&nbsp;high short interest&nbsp;since the beginning of the global pandemic in 2020. Stocks like Koss are great swing trading plays, but make for terrible long-term investments. If you're looking for an upside with high risk, then turn your attention to the smallest meme stock based on market cap.</p>\n<p><b>Koss's Business Model</b></p>\n<p>Koss makes headphones and I remember owning a cheap pair of Koss stereo headphones back when I was a kid growing up in Washington DC.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e95dc4b8abb3cfd7b46768b728106912\" tg-width=\"640\" tg-height=\"640\"><span>Source: Koss.com</span></p>\n<p>Since then, big tech companies like Apple (AAPL) entered the headphone market and stole market share from longstanding headphone makers.</p>\n<p>Koss reported just under $5 million&nbsp;in total revenue for the quarter ending December 31, 2020. Net income per share equaled 7 cents (up from 3 cents during the same period in 2019). Many Americans were forced to work from home during the global pandemic, which helped lift electronic accessory sales nationwide. TTM sales are around $18 million, and the company has a cash position of $4.39 million. With a market cap of around $192 million, Koss stock trades at a reasonable P/S ratio but lacks significant revenue growth in the future.</p>\n<p>Koss is a small, yet profitable company but doesn't possess big upside like other big tech companies. However, that didn't stop retail traders from targeting the 63-year-old company as a prime target for an epic short squeeze.</p>\n<p><b>The Koss Short Squeeze Explained</b></p>\n<p>In late January, Reddit users of the subreddit \"WallStreetBets\" decided to team up and earn billions of dollars in profits by targeting low float stocks with high short positions. The goal was to force hedge funds with short positions to buy back the stock at a higher price to create a short squeeze. Short sellers borrow shares of a stock, then sell them off with hopes of buying back the stock at a cheaper price to earn a profit.</p>\n<p>However, WallStreetBets realized that Wall Street short sellers made a critical error. Koss had a high short interest of over 38% percent with a low float. With only a float of 3 million, any massive increase in buying power would send the stock soaring and force shorts to cover their losing positions.</p>\n<p>Koss stock did just that.</p>\n<p>KOSS jumped from $3.34 to $10 between January 22nd and 26th, then skyrocketed to an all-time high of $127.Robinhood famously stepped in and deleted the buy button&nbsp;to put an end to the epic short squeeze.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/60ee1f3d2437467a9c7dee1572cbb0c6\" tg-width=\"635\" tg-height=\"403\"><span>Data by YCharts</span></p>\n<p>Now that the dust has settled, Koss has a much lower short interest of 14% and the WSB crowd has shifted its sights on other short squeeze targets.</p>\n<p><b>How to Profit from Koss During the Next Short Squeeze</b></p>\n<p>I cannot recommend Koss as a good, long-term investment because I mainly write about hyper growth stocks that can return at least 30% to 40% annually. Koss is an old dinosaur of a company with little hope for future growth.</p>\n<p>But there is a way to profit from the next Koss short squeeze if it happens.</p>\n<p>The best way to play Koss stock is to monitor theRSI(relative strength index) and volume. RSI is my favorite technical analysis indicator to determine whether a stock is overbought or oversold. We want to monitor KOSS stock when it gets \"boring\" and the RSI dips to around 50 or below.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/56e3c62dab17827007451bf5fa2fe2a4\" tg-width=\"635\" tg-height=\"403\"><span>Data by YCharts</span></p>\n<p>Unfortunately, novice traders make the classic mistake of buying what's popular and exposing themselves to the potential for massive losses. People who bought KOSS at $100 or more believed the stock could go to $200, but in reality, they lost a ton of money and probably stopped trading stocks altogether.</p>\n<p>Koss had an RSI of 90 at its peak, signaling it was time to sell and get out of the stock. Monitor the RSI will help you avoid \"buying at the top\" and reduce your exposure to massive trading losses.</p>\n<p>Volume is another key indicator that will give us information on when to enter the trade. Wait for volume spikes before buying the stock because you don't want to hold KOSS shares in anticipation of a bullish move. Set up an alert to notify you when Koss stock volume is up or just monitor&nbsp;Yahoo! Finance Trending Tickers&nbsp;to find a good entry point.</p>\n<p>My strategy is to buy Koss stock when the RSI is near or below 50, then sell it once it reaches 65 or more. It's a sound strategy that will protect you from losses because you must limit downside risk.</p>\n<p><b>Risk Factors: Inflated Stock Prices Due to Massive Hype</b></p>\n<p>As I mentioned above, too many novice traders \"buy the hype\" and expose themselves to huge losses.</p>\n<p>Meme stocks trade on hype instead of fundamentals. If you really think that Koss stock will keep soaring when the underlying business earns $18 million annually, then you will lose your shirt. Never buy the hype or chase a bullish runup. Wait for a good entry position at a much cheaper price when the next bullish run happens.</p>\n<p>There are literally thousands of stocks to choose from every day. No reason to chase gains or FOMO.</p>\n<p><b>Conclusion</b></p>\n<p>Koss is a small electronics company that hasn't shown signs of hypergrowth potential. The best strategy for Koss shares is to buy low during higher volume, then dump the stock once the RSI gets too high.</p>\n<p>I don't recommend Koss as a long-term investment and prefer Apple stock over the long term. If you must chase massive gains trading meme stocks like Koss, then protect yourself at all costs and don't buy the hype.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Koss: Don't Buy The Hype On This Highly Shorted Meme Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKoss: Don't Buy The Hype On This Highly Shorted Meme Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-15 12:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4413768-koss-dont-buy-hype-shorted-meme-stock><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nKoss is a small electronics company that got caught up in the meme stock runup, but has little hope for massive growth in the future.\nMeme stocks trade on hype instead of fundamentals, so be ...</p>\n\n<a href=\"https://seekingalpha.com/article/4413768-koss-dont-buy-hype-shorted-meme-stock\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KOSS":"高斯电子"},"source_url":"https://seekingalpha.com/article/4413768-koss-dont-buy-hype-shorted-meme-stock","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1108838813","content_text":"Summary\n\nKoss is a small electronics company that got caught up in the meme stock runup, but has little hope for massive growth in the future.\nMeme stocks trade on hype instead of fundamentals, so be careful not to lose your shirt.\nKoss offers massive upside during the next short squeeze, but should be avoided as a long-term investment.\n\nKoss(NASDAQ:KOSS)is a headphone and electronic accessories company that has gotten a lot of attention recently due to the rise of \"Meme Stocks\" like GameStop (GME) and AMC (AMC).\nRetail traders began focusing on stocks with low float and high short interest since the beginning of the global pandemic in 2020. Stocks like Koss are great swing trading plays, but make for terrible long-term investments. If you're looking for an upside with high risk, then turn your attention to the smallest meme stock based on market cap.\nKoss's Business Model\nKoss makes headphones and I remember owning a cheap pair of Koss stereo headphones back when I was a kid growing up in Washington DC.\nSource: Koss.com\nSince then, big tech companies like Apple (AAPL) entered the headphone market and stole market share from longstanding headphone makers.\nKoss reported just under $5 million in total revenue for the quarter ending December 31, 2020. Net income per share equaled 7 cents (up from 3 cents during the same period in 2019). Many Americans were forced to work from home during the global pandemic, which helped lift electronic accessory sales nationwide. TTM sales are around $18 million, and the company has a cash position of $4.39 million. With a market cap of around $192 million, Koss stock trades at a reasonable P/S ratio but lacks significant revenue growth in the future.\nKoss is a small, yet profitable company but doesn't possess big upside like other big tech companies. However, that didn't stop retail traders from targeting the 63-year-old company as a prime target for an epic short squeeze.\nThe Koss Short Squeeze Explained\nIn late January, Reddit users of the subreddit \"WallStreetBets\" decided to team up and earn billions of dollars in profits by targeting low float stocks with high short positions. The goal was to force hedge funds with short positions to buy back the stock at a higher price to create a short squeeze. Short sellers borrow shares of a stock, then sell them off with hopes of buying back the stock at a cheaper price to earn a profit.\nHowever, WallStreetBets realized that Wall Street short sellers made a critical error. Koss had a high short interest of over 38% percent with a low float. With only a float of 3 million, any massive increase in buying power would send the stock soaring and force shorts to cover their losing positions.\nKoss stock did just that.\nKOSS jumped from $3.34 to $10 between January 22nd and 26th, then skyrocketed to an all-time high of $127.Robinhood famously stepped in and deleted the buy button to put an end to the epic short squeeze.\nData by YCharts\nNow that the dust has settled, Koss has a much lower short interest of 14% and the WSB crowd has shifted its sights on other short squeeze targets.\nHow to Profit from Koss During the Next Short Squeeze\nI cannot recommend Koss as a good, long-term investment because I mainly write about hyper growth stocks that can return at least 30% to 40% annually. Koss is an old dinosaur of a company with little hope for future growth.\nBut there is a way to profit from the next Koss short squeeze if it happens.\nThe best way to play Koss stock is to monitor theRSI(relative strength index) and volume. RSI is my favorite technical analysis indicator to determine whether a stock is overbought or oversold. We want to monitor KOSS stock when it gets \"boring\" and the RSI dips to around 50 or below.\nData by YCharts\nUnfortunately, novice traders make the classic mistake of buying what's popular and exposing themselves to the potential for massive losses. People who bought KOSS at $100 or more believed the stock could go to $200, but in reality, they lost a ton of money and probably stopped trading stocks altogether.\nKoss had an RSI of 90 at its peak, signaling it was time to sell and get out of the stock. Monitor the RSI will help you avoid \"buying at the top\" and reduce your exposure to massive trading losses.\nVolume is another key indicator that will give us information on when to enter the trade. Wait for volume spikes before buying the stock because you don't want to hold KOSS shares in anticipation of a bullish move. Set up an alert to notify you when Koss stock volume is up or just monitor Yahoo! Finance Trending Tickers to find a good entry point.\nMy strategy is to buy Koss stock when the RSI is near or below 50, then sell it once it reaches 65 or more. It's a sound strategy that will protect you from losses because you must limit downside risk.\nRisk Factors: Inflated Stock Prices Due to Massive Hype\nAs I mentioned above, too many novice traders \"buy the hype\" and expose themselves to huge losses.\nMeme stocks trade on hype instead of fundamentals. If you really think that Koss stock will keep soaring when the underlying business earns $18 million annually, then you will lose your shirt. Never buy the hype or chase a bullish runup. Wait for a good entry position at a much cheaper price when the next bullish run happens.\nThere are literally thousands of stocks to choose from every day. No reason to chase gains or FOMO.\nConclusion\nKoss is a small electronics company that hasn't shown signs of hypergrowth potential. The best strategy for Koss shares is to buy low during higher volume, then dump the stock once the RSI gets too high.\nI don't recommend Koss as a long-term investment and prefer Apple stock over the long term. If you must chase massive gains trading meme stocks like Koss, then protect yourself at all costs and don't buy the hype.","news_type":1},"isVote":1,"tweetType":1,"viewCount":204,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":340775440,"gmtCreate":1617500426080,"gmtModify":1704700009230,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577157678952273","idStr":"3577157678952273"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/340775440","repostId":"2124875875","repostType":4,"repost":{"id":"2124875875","pubTimestamp":1617366960,"share":"https://ttm.financial/m/news/2124875875?lang=&edition=fundamental","pubTime":"2021-04-02 20:36","market":"us","language":"en","title":"Tesla Q1 2021 Vehicle Production & Deliveries","url":"https://stock-news.laohu8.com/highlight/detail?id=2124875875","media":"StreetInsider","summary":"PALO ALTO, Calif., April 02, 2021  -- In the first quarter, we produced just over 180,000 vehicles and delivered nearly 185,000 vehicles. We are encouraged by the strong reception of the Model Y in China and are quickly progressing to full production capacity. The new Model S and Model X have also been exceptionally well received, with the new equipment installed and tested in Q1 and we are in the early stages of ramping production.Forward-Looking Statements Statements herein regarding the timin","content":"<p>PALO ALTO, Calif., April 02, 2021 (GLOBE NEWSWIRE) -- In the first quarter, we produced just over 180,000 vehicles and delivered nearly 185,000 vehicles. We are encouraged by the strong reception of the Model Y in China and are quickly progressing to full production capacity. The new Model S and Model X have also been exceptionally well received, with the new equipment installed and tested in Q1 and we are in the early stages of ramping production.</p>\n<table>\n <tbody>\n  <tr>\n   <td></td>\n   <td><b>Production</b></td>\n   <td><b>Deliveries</b></td>\n   <td><b>Subject to operating lease accounting</b></td>\n  </tr>\n  <tr>\n   <td>Model S/X</td>\n   <td>-</td>\n   <td>2,020</td>\n   <td>6%</td>\n  </tr>\n  <tr>\n   <td>Model 3/Y</td>\n   <td>180,338</td>\n   <td>182,780</td>\n   <td>7%</td>\n  </tr>\n  <tr>\n   <td><b>Total</b></td>\n   <td><b>180,338</b></td>\n   <td><b>184,800</b></td>\n   <td><b>7%</b></td>\n  </tr>\n </tbody>\n</table>\n<p>***************</p>\n<p>Our net income and cash flow results will be announced along with the rest of our financial performance when we announce Q1 earnings. Our delivery count should be viewed as slightly conservative, as we only count a car as delivered if it is transferred to the customer and all paperwork is correct. Final numbers could vary by up to 0.5% or more. Tesla vehicle deliveries represent only <a href=\"https://laohu8.com/S/AONE\">one</a> measure of the company’s financial performance and should not be relied on as an indicator of quarterly financial results, which depend on a variety of factors, including the cost of sales, foreign exchange movements and mix of directly leased vehicles.</p>\n<p><b>Forward-Looking Statements</b>&nbsp;Statements herein regarding the timing and future progress of our vehicle production ramp are “forward-looking statements” based on management’s current expectations and that are subject to risks and uncertainties. Various important factors could cause actual results to differ materially, including the risks identified in our SEC filings. Tesla disclaims any obligation to update this information.</p>\n<p><img src=\"https://static.tigerbbs.com/db04c7b378cb2db912c3ba8a5a774ee3\" tg-width=\"1\" tg-height=\"1\" referrerpolicy=\"no-referrer\"></p>\n<p><img src=\"https://static.tigerbbs.com/c2196de8ba412c60c22ab491af7b1409\" tg-width=\"1\" tg-height=\"1\" referrerpolicy=\"no-referrer\"></p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Q1 2021 Vehicle Production & Deliveries</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Q1 2021 Vehicle Production & Deliveries\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-02 20:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18215929><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>PALO ALTO, Calif., April 02, 2021 (GLOBE NEWSWIRE) -- In the first quarter, we produced just over 180,000 vehicles and delivered nearly 185,000 vehicles. We are encouraged by the strong reception of ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18215929\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18215929","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2124875875","content_text":"PALO ALTO, Calif., April 02, 2021 (GLOBE NEWSWIRE) -- In the first quarter, we produced just over 180,000 vehicles and delivered nearly 185,000 vehicles. We are encouraged by the strong reception of the Model Y in China and are quickly progressing to full production capacity. The new Model S and Model X have also been exceptionally well received, with the new equipment installed and tested in Q1 and we are in the early stages of ramping production.\n\n\n\n\nProduction\nDeliveries\nSubject to operating lease accounting\n\n\nModel S/X\n-\n2,020\n6%\n\n\nModel 3/Y\n180,338\n182,780\n7%\n\n\nTotal\n180,338\n184,800\n7%\n\n\n\n***************\nOur net income and cash flow results will be announced along with the rest of our financial performance when we announce Q1 earnings. Our delivery count should be viewed as slightly conservative, as we only count a car as delivered if it is transferred to the customer and all paperwork is correct. Final numbers could vary by up to 0.5% or more. Tesla vehicle deliveries represent only one measure of the company’s financial performance and should not be relied on as an indicator of quarterly financial results, which depend on a variety of factors, including the cost of sales, foreign exchange movements and mix of directly leased vehicles.\nForward-Looking Statements Statements herein regarding the timing and future progress of our vehicle production ramp are “forward-looking statements” based on management’s current expectations and that are subject to risks and uncertainties. Various important factors could cause actual results to differ materially, including the risks identified in our SEC filings. Tesla disclaims any obligation to update this information.","news_type":1},"isVote":1,"tweetType":1,"viewCount":191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":349219322,"gmtCreate":1617614516866,"gmtModify":1704700851651,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577157678952273","idStr":"3577157678952273"},"themes":[],"htmlText":"Interesting&nbsp;","listText":"Interesting&nbsp;","text":"Interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/349219322","repostId":"1102809338","repostType":4,"repost":{"id":"1102809338","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1617611226,"share":"https://ttm.financial/m/news/1102809338?lang=&edition=fundamental","pubTime":"2021-04-05 16:27","market":"us","language":"en","title":"5 Stocks Top Analysts Are Bullish On At The Start Of Q2","url":"https://stock-news.laohu8.com/highlight/detail?id=1102809338","media":"Benzinga","summary":"The U.S. President Joe Biden’s unveiling of the $2.3 trillion infrastructure plan aimed at rebuildin","content":"<p>The U.S. President Joe Biden’s&nbsp;unveiling&nbsp;of the&nbsp;$2.3 trillion infrastructure plan&nbsp;aimed at rebuilding American roads, bridges, mass transit, and water infrastructure, has boosted the U.S. market’s morale heading into the second quarter of the year. . But more immediate concerns continue to stoke fear among Wall Street investors as the number of coronavirus cases across the globe continues to rise.</p>\n<p>In these circumstances, top wall street analysts are favoring the following five stocks, as&nbsp;compiledby TipRanks for CNBC.</p>\n<p>Here’s a list of the best-performing Wall Street analysts’&nbsp;five favorite stocks&nbsp;right now, as compiled by TipRanks.</p>\n<p><b>Facebook Inc</b>&nbsp;(NASDAQ:FB): Monness analyst Brian White continues to remain bullish on the social media giant despite a recentHouse hearingwhich grilled the CEOs of Facebook,&nbsp;<b>Alphabet Inc</b>(NASDAQ:GOOGL), and&nbsp;<b>Twitter Inc</b>(NYSE:TWTR) on misinformation.</p>\n<p>The analyst reiterated a “Buy” rating on the stock and maintained a $375 price target, implying a 27% upside potential.</p>\n<p>According to White, Facebook CEP appeared well-prepared, thoughtful, professional and respectful of the issues at stake and open to improving the social-media platform during the hearing.</p>\n<p>Though, according to White, the hearing brought to fore certain serious issues that have been brought about by social media and meaningful changes are imperative, the hearing was a “brazen political grandstanding on both sides of the aisle,” and that lawmakers were trying to appeal to local constituents.</p>\n<p>The subcommittee members also called for the “break up of Big Tech,” and as per White if such events takes place, the valuation of Facebook and other big tech companies could jump even higher.</p>\n<p>As one of the top 75 analysts tracked by TipRanks, White’s calls see an average annual return of 28.2%, with the success rate landing at 73%.</p>\n<p>Shares of Facebook closed 1.4% higher at $298.66 on Thursday and have a 52-week high of $304.67 and low of $150.83.</p>\n<p><b>Micron Technology Inc</b>(NASDAQ:MU): RBC Capital analyst Mitch Steves reiterated a “Buy” rating and raised the price target to $120 from $110 on the stock, implying a 36% upside potential.</p>\n<p>Steves’ price target raise comes after the chipmaker's quarterly earnings beat last week and a better-than-expected outlook. The analyst notes that Micron’s gross margins are “expanding rapidly considering that the firm guided to 41.5% gross margins at the midpoint.”</p>\n<p>The Wall Street Journal reported last week that&nbsp;Micron and Western Digital&nbsp;are considering a deal that would result in the acquisition of Kioxia for about $30 billion.</p>\n<p>Steves has a 76% success rate and 35.2% average return per rating and is among the top 30 analysts tracked by TipRanks.</p>\n<p>Shares of Micron closed 4.76% higher at $92.41 on Thursday and has a 52-week high of $95.75 and low of $39.52.</p>\n<p><b>Benchmark Electronics Inc</b>&nbsp;(NYSE:BHE): Needham’s James Ricchiuti has upgraded the electronic manufacturing services (EMS) stock to “Buy” rating from “Hold,” in addition to a $35 price target, spurred by increased confidence in its growth as well as the margin.</p>\n<p>The five-star analyst believes noted that there is positive commentary coming in from the semiconductor-capital market, including from&nbsp;<b>Applied Materials Inc.</b>, the company’s largest customer, and that his previous expectations could be “conservative.”</p>\n<p>Despite the pandemic, Benchmark reported a strong bookings momentum in 2020 and the analyst expects the company's 5% top-line growth targets through 2022 as reasonable in an improving economy.</p>\n<p>Also, strength in defense could offset headwinds in the commercial aerospace part of the A&amp;D business.</p>\n<p>With a 67% success rate and 23.5% average return per rating, Ricchiuti is ranked 83 on TipRanks’ list of best-performing analysts.</p>\n<p>Shares of Benchmark closed 1.39% higher at $31.35 on Thursday and has a 52-week high of $32.16 and low of $17.87.</p>\n<p><b>Lantheus Holdings</b>(NASDAQ:LNTH): SVB Leerink analyst Richard Newitter has reiterated a “Buy” rating and maintained the $25 price target on the stock, implying a potential 17% upside in the store.</p>\n<p>Newitter expects Lantheus, which develops products that help healthcare providers identify diseases, to benefit from its recent acquisition of the global rights to Noria Therapeutics’ NTI-1309,&nbsp; a PET oncology imaging agent.</p>\n<p>According to the deal, Lantheus will have the exclusive rights to develop, manufacture, and commercialize NTI-1309.</p>\n<p>“NTI-1309 has the potential to broaden Lantheus’ reach beyond prostate cancer…through additional diagnostic biomarker targeting and pharma service capabilities into other cancer types,” according to Newitter.</p>\n<p>The analyst expects the company to sustain a roughly 20% 2020 –2023E revenue CAGR as it uses its expanding diagnostic image enhancing solutions pipeline to “target sizable, rapidly growing and underpenetrated cardio/oncology market opportunities.”</p>\n<p>Landing the 178 spot on TipRanks’ ranking, Newitter has achieved a 71% success rate and 26.9% average return per rating.</p>\n<p>Shares of Lantheus closed 1.73% lower at $21 on Thursday and have a 52-week high of $21.99 and low of $10.21.</p>\n<p><b>Marvell Technology Group</b>(NASDAQ:MRVL): Susquehanna analyst Christopher Rolland has maintained a “Buy” rating on the stock and raised the price target to $62 from $60 to reflect increased visibility. This new target implies 27% upside potential from current levels.</p>\n<p>Rolland’s price target raise follows an analyst call with Marvell CEO Matt Murphy on the company’s ASIC strategy and the semiconductor company’s long-term growth prospects.</p>\n<p>“Overall, management believes custom ASICs (5G, Cloud, Auto) could be billions of dollars of opportunities five years from now. The Inphi addition and its strong optics position should be an accelerator and attractant for new ASIC businesses more broadly,” according to Rolland.</p>\n<p>Financially, the analyst believes that ASICs will only modestly impact gross margins, but other areas like NRE could give operating margins a boost.</p>\n<p>A top 50-ranked analyst, Rolland boasts a 74% success rate and 21.7% average return per rating.</p>\n<p>Shares of Marvell closed 1.39% higher at $49.66 on Thursday and have a 52-week high of $55.70 and low of $21.29.</p>\n<p><img src=\"https://static.tigerbbs.com/087104df237a2dfb2198d878f5f1d3b5\" tg-width=\"1041\" tg-height=\"243\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks Top Analysts Are Bullish On At The Start Of Q2</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks Top Analysts Are Bullish On At The Start Of Q2\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-04-05 16:27</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>The U.S. President Joe Biden’s&nbsp;unveiling&nbsp;of the&nbsp;$2.3 trillion infrastructure plan&nbsp;aimed at rebuilding American roads, bridges, mass transit, and water infrastructure, has boosted the U.S. market’s morale heading into the second quarter of the year. . But more immediate concerns continue to stoke fear among Wall Street investors as the number of coronavirus cases across the globe continues to rise.</p>\n<p>In these circumstances, top wall street analysts are favoring the following five stocks, as&nbsp;compiledby TipRanks for CNBC.</p>\n<p>Here’s a list of the best-performing Wall Street analysts’&nbsp;five favorite stocks&nbsp;right now, as compiled by TipRanks.</p>\n<p><b>Facebook Inc</b>&nbsp;(NASDAQ:FB): Monness analyst Brian White continues to remain bullish on the social media giant despite a recentHouse hearingwhich grilled the CEOs of Facebook,&nbsp;<b>Alphabet Inc</b>(NASDAQ:GOOGL), and&nbsp;<b>Twitter Inc</b>(NYSE:TWTR) on misinformation.</p>\n<p>The analyst reiterated a “Buy” rating on the stock and maintained a $375 price target, implying a 27% upside potential.</p>\n<p>According to White, Facebook CEP appeared well-prepared, thoughtful, professional and respectful of the issues at stake and open to improving the social-media platform during the hearing.</p>\n<p>Though, according to White, the hearing brought to fore certain serious issues that have been brought about by social media and meaningful changes are imperative, the hearing was a “brazen political grandstanding on both sides of the aisle,” and that lawmakers were trying to appeal to local constituents.</p>\n<p>The subcommittee members also called for the “break up of Big Tech,” and as per White if such events takes place, the valuation of Facebook and other big tech companies could jump even higher.</p>\n<p>As one of the top 75 analysts tracked by TipRanks, White’s calls see an average annual return of 28.2%, with the success rate landing at 73%.</p>\n<p>Shares of Facebook closed 1.4% higher at $298.66 on Thursday and have a 52-week high of $304.67 and low of $150.83.</p>\n<p><b>Micron Technology Inc</b>(NASDAQ:MU): RBC Capital analyst Mitch Steves reiterated a “Buy” rating and raised the price target to $120 from $110 on the stock, implying a 36% upside potential.</p>\n<p>Steves’ price target raise comes after the chipmaker's quarterly earnings beat last week and a better-than-expected outlook. The analyst notes that Micron’s gross margins are “expanding rapidly considering that the firm guided to 41.5% gross margins at the midpoint.”</p>\n<p>The Wall Street Journal reported last week that&nbsp;Micron and Western Digital&nbsp;are considering a deal that would result in the acquisition of Kioxia for about $30 billion.</p>\n<p>Steves has a 76% success rate and 35.2% average return per rating and is among the top 30 analysts tracked by TipRanks.</p>\n<p>Shares of Micron closed 4.76% higher at $92.41 on Thursday and has a 52-week high of $95.75 and low of $39.52.</p>\n<p><b>Benchmark Electronics Inc</b>&nbsp;(NYSE:BHE): Needham’s James Ricchiuti has upgraded the electronic manufacturing services (EMS) stock to “Buy” rating from “Hold,” in addition to a $35 price target, spurred by increased confidence in its growth as well as the margin.</p>\n<p>The five-star analyst believes noted that there is positive commentary coming in from the semiconductor-capital market, including from&nbsp;<b>Applied Materials Inc.</b>, the company’s largest customer, and that his previous expectations could be “conservative.”</p>\n<p>Despite the pandemic, Benchmark reported a strong bookings momentum in 2020 and the analyst expects the company's 5% top-line growth targets through 2022 as reasonable in an improving economy.</p>\n<p>Also, strength in defense could offset headwinds in the commercial aerospace part of the A&amp;D business.</p>\n<p>With a 67% success rate and 23.5% average return per rating, Ricchiuti is ranked 83 on TipRanks’ list of best-performing analysts.</p>\n<p>Shares of Benchmark closed 1.39% higher at $31.35 on Thursday and has a 52-week high of $32.16 and low of $17.87.</p>\n<p><b>Lantheus Holdings</b>(NASDAQ:LNTH): SVB Leerink analyst Richard Newitter has reiterated a “Buy” rating and maintained the $25 price target on the stock, implying a potential 17% upside in the store.</p>\n<p>Newitter expects Lantheus, which develops products that help healthcare providers identify diseases, to benefit from its recent acquisition of the global rights to Noria Therapeutics’ NTI-1309,&nbsp; a PET oncology imaging agent.</p>\n<p>According to the deal, Lantheus will have the exclusive rights to develop, manufacture, and commercialize NTI-1309.</p>\n<p>“NTI-1309 has the potential to broaden Lantheus’ reach beyond prostate cancer…through additional diagnostic biomarker targeting and pharma service capabilities into other cancer types,” according to Newitter.</p>\n<p>The analyst expects the company to sustain a roughly 20% 2020 –2023E revenue CAGR as it uses its expanding diagnostic image enhancing solutions pipeline to “target sizable, rapidly growing and underpenetrated cardio/oncology market opportunities.”</p>\n<p>Landing the 178 spot on TipRanks’ ranking, Newitter has achieved a 71% success rate and 26.9% average return per rating.</p>\n<p>Shares of Lantheus closed 1.73% lower at $21 on Thursday and have a 52-week high of $21.99 and low of $10.21.</p>\n<p><b>Marvell Technology Group</b>(NASDAQ:MRVL): Susquehanna analyst Christopher Rolland has maintained a “Buy” rating on the stock and raised the price target to $62 from $60 to reflect increased visibility. This new target implies 27% upside potential from current levels.</p>\n<p>Rolland’s price target raise follows an analyst call with Marvell CEO Matt Murphy on the company’s ASIC strategy and the semiconductor company’s long-term growth prospects.</p>\n<p>“Overall, management believes custom ASICs (5G, Cloud, Auto) could be billions of dollars of opportunities five years from now. The Inphi addition and its strong optics position should be an accelerator and attractant for new ASIC businesses more broadly,” according to Rolland.</p>\n<p>Financially, the analyst believes that ASICs will only modestly impact gross margins, but other areas like NRE could give operating margins a boost.</p>\n<p>A top 50-ranked analyst, Rolland boasts a 74% success rate and 21.7% average return per rating.</p>\n<p>Shares of Marvell closed 1.39% higher at $49.66 on Thursday and have a 52-week high of $55.70 and low of $21.29.</p>\n<p><img src=\"https://static.tigerbbs.com/087104df237a2dfb2198d878f5f1d3b5\" tg-width=\"1041\" tg-height=\"243\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MU":"美光科技","MRVL":"迈威尔科技","LNTH":"Lantheus Holdings, Inc.","BHE":"Benchmark Electronics Inc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102809338","content_text":"The U.S. President Joe Biden’s unveiling of the $2.3 trillion infrastructure plan aimed at rebuilding American roads, bridges, mass transit, and water infrastructure, has boosted the U.S. market’s morale heading into the second quarter of the year. . But more immediate concerns continue to stoke fear among Wall Street investors as the number of coronavirus cases across the globe continues to rise.\nIn these circumstances, top wall street analysts are favoring the following five stocks, as compiledby TipRanks for CNBC.\nHere’s a list of the best-performing Wall Street analysts’ five favorite stocks right now, as compiled by TipRanks.\nFacebook Inc (NASDAQ:FB): Monness analyst Brian White continues to remain bullish on the social media giant despite a recentHouse hearingwhich grilled the CEOs of Facebook, Alphabet Inc(NASDAQ:GOOGL), and Twitter Inc(NYSE:TWTR) on misinformation.\nThe analyst reiterated a “Buy” rating on the stock and maintained a $375 price target, implying a 27% upside potential.\nAccording to White, Facebook CEP appeared well-prepared, thoughtful, professional and respectful of the issues at stake and open to improving the social-media platform during the hearing.\nThough, according to White, the hearing brought to fore certain serious issues that have been brought about by social media and meaningful changes are imperative, the hearing was a “brazen political grandstanding on both sides of the aisle,” and that lawmakers were trying to appeal to local constituents.\nThe subcommittee members also called for the “break up of Big Tech,” and as per White if such events takes place, the valuation of Facebook and other big tech companies could jump even higher.\nAs one of the top 75 analysts tracked by TipRanks, White’s calls see an average annual return of 28.2%, with the success rate landing at 73%.\nShares of Facebook closed 1.4% higher at $298.66 on Thursday and have a 52-week high of $304.67 and low of $150.83.\nMicron Technology Inc(NASDAQ:MU): RBC Capital analyst Mitch Steves reiterated a “Buy” rating and raised the price target to $120 from $110 on the stock, implying a 36% upside potential.\nSteves’ price target raise comes after the chipmaker's quarterly earnings beat last week and a better-than-expected outlook. The analyst notes that Micron’s gross margins are “expanding rapidly considering that the firm guided to 41.5% gross margins at the midpoint.”\nThe Wall Street Journal reported last week that Micron and Western Digital are considering a deal that would result in the acquisition of Kioxia for about $30 billion.\nSteves has a 76% success rate and 35.2% average return per rating and is among the top 30 analysts tracked by TipRanks.\nShares of Micron closed 4.76% higher at $92.41 on Thursday and has a 52-week high of $95.75 and low of $39.52.\nBenchmark Electronics Inc (NYSE:BHE): Needham’s James Ricchiuti has upgraded the electronic manufacturing services (EMS) stock to “Buy” rating from “Hold,” in addition to a $35 price target, spurred by increased confidence in its growth as well as the margin.\nThe five-star analyst believes noted that there is positive commentary coming in from the semiconductor-capital market, including from Applied Materials Inc., the company’s largest customer, and that his previous expectations could be “conservative.”\nDespite the pandemic, Benchmark reported a strong bookings momentum in 2020 and the analyst expects the company's 5% top-line growth targets through 2022 as reasonable in an improving economy.\nAlso, strength in defense could offset headwinds in the commercial aerospace part of the A&D business.\nWith a 67% success rate and 23.5% average return per rating, Ricchiuti is ranked 83 on TipRanks’ list of best-performing analysts.\nShares of Benchmark closed 1.39% higher at $31.35 on Thursday and has a 52-week high of $32.16 and low of $17.87.\nLantheus Holdings(NASDAQ:LNTH): SVB Leerink analyst Richard Newitter has reiterated a “Buy” rating and maintained the $25 price target on the stock, implying a potential 17% upside in the store.\nNewitter expects Lantheus, which develops products that help healthcare providers identify diseases, to benefit from its recent acquisition of the global rights to Noria Therapeutics’ NTI-1309,  a PET oncology imaging agent.\nAccording to the deal, Lantheus will have the exclusive rights to develop, manufacture, and commercialize NTI-1309.\n“NTI-1309 has the potential to broaden Lantheus’ reach beyond prostate cancer…through additional diagnostic biomarker targeting and pharma service capabilities into other cancer types,” according to Newitter.\nThe analyst expects the company to sustain a roughly 20% 2020 –2023E revenue CAGR as it uses its expanding diagnostic image enhancing solutions pipeline to “target sizable, rapidly growing and underpenetrated cardio/oncology market opportunities.”\nLanding the 178 spot on TipRanks’ ranking, Newitter has achieved a 71% success rate and 26.9% average return per rating.\nShares of Lantheus closed 1.73% lower at $21 on Thursday and have a 52-week high of $21.99 and low of $10.21.\nMarvell Technology Group(NASDAQ:MRVL): Susquehanna analyst Christopher Rolland has maintained a “Buy” rating on the stock and raised the price target to $62 from $60 to reflect increased visibility. This new target implies 27% upside potential from current levels.\nRolland’s price target raise follows an analyst call with Marvell CEO Matt Murphy on the company’s ASIC strategy and the semiconductor company’s long-term growth prospects.\n“Overall, management believes custom ASICs (5G, Cloud, Auto) could be billions of dollars of opportunities five years from now. The Inphi addition and its strong optics position should be an accelerator and attractant for new ASIC businesses more broadly,” according to Rolland.\nFinancially, the analyst believes that ASICs will only modestly impact gross margins, but other areas like NRE could give operating margins a boost.\nA top 50-ranked analyst, Rolland boasts a 74% success rate and 21.7% average return per rating.\nShares of Marvell closed 1.39% higher at $49.66 on Thursday and have a 52-week high of $55.70 and low of $21.29.","news_type":1},"isVote":1,"tweetType":1,"viewCount":331,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":352188278,"gmtCreate":1616907511994,"gmtModify":1704799891717,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577157678952273","idStr":"3577157678952273"},"themes":[],"htmlText":"Ok ok ok","listText":"Ok ok ok","text":"Ok ok ok","images":[{"img":"https://static.tigerbbs.com/3437ad98e22ee68381fb11f71cbfa8b7","width":"1125","height":"3556"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/352188278","isVote":1,"tweetType":1,"viewCount":487,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":320233921,"gmtCreate":1615110093963,"gmtModify":1704778720039,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577157678952273","idStr":"3577157678952273"},"themes":[],"htmlText":"........","listText":"........","text":"........","images":[{"img":"https://static.tigerbbs.com/760477c6fb49af73d085ea0327019170","width":"1125","height":"3114"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/320233921","isVote":1,"tweetType":1,"viewCount":371,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":366138611,"gmtCreate":1614406966433,"gmtModify":1704771625232,"author":{"id":"3577157678952273","authorId":"3577157678952273","name":"H_Shan","avatar":"https://static.tigerbbs.com/28447deeffe1e05c67f2e427546c93d4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3577157678952273","idStr":"3577157678952273"},"themes":[],"htmlText":"Is this for long term?","listText":"Is this for long term?","text":"Is this for long term?","images":[{"img":"https://static.tigerbbs.com/2eda99c6844e002795f702b350c203aa","width":"1125","height":"3070"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/366138611","isVote":1,"tweetType":1,"viewCount":128,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}